For utfyllende beskrivelse av tidligere publikasjoner og forskningsaktivitet ved senteret se
årsrapportene.
2021
König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations. J Neurol Neurosurg Psychiatry 2021 Oct 20. Epub 2021 okt 20 PMID: 34670844
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis. Mult Scler J Exp Transl Clin 2021 Apr-Jun;7(2):20552173211022027. Epub 2021 jun 14 PMID: 34188949
Eid K, Torkildsen ØF, Aarseth J, Flemmen HØ, Holmøy T, Lorentzen ÅR, Myhr KM, Riise T, Simonsen C, Torkildsen CF, Wergeland S, Willumsen JS, Øksendal N, Gilhus NE, Bjørk MH Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study. Neurology 2021 06 08;96(23):e2789-e2800. Epub 2021 apr 21 PMID:
33883236
Wesnes K, Myhr KM, Riise T, Kvistad SS, Torkildsen Ø, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Bjørnevik K Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Mult Scler Relat Disord 2021 May;50():102801. Epub 2021 jan 28 PMID: 33636616
33360174
Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study. Neurology 2021 12 07;97(23):e2253-e2261. Epub 2021 okt 25 PMID: 34697245
Mult Scler J Exp Transl Clin 2021 Jan-Mar;7(1):2055217320973049. Epub 2021 jan 31
PMID: 33796328
Torkildsen Ø Serum markers of multiple sclerosis - a new approach. EBioMedicine 2021 Feb;64():103229. Epub 2021 jan 28 PMID: 33516064
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Mult Scler J Exp Transl Clin 2021 Oct;7(4):20552173211060337. Epub 2021 des 6 PMID: 34900328
PMID: 33785790
Mosleth EF, Vedeler CA, Liland KH, McLeod A, Bringeland GH, Kroondijk L, Berven FS, Lysenko A, Rawlings CJ, Eid KE, Opsahl JA, Gjertsen BT, Myhr KM, Gavasso S Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. Sci Rep 2021 02 18;11(1):4087. Epub 2021 feb 18 PMID: 33602999
Holmøy T, Nygaard GO, Myhr KM, Bø L. Disease-modifying therapy for multiple sclerosis. Tidsskr Nor Laegeforen. 2021 May 10;141(8). doi: 10.4045/tidsskr.21.0155. Print 2021 May 25.
Kønig M, Torgauten HM, Øverås MH, Chopra A, Lorentzen ÅR, Tran T, Mjaaland S, Aaberge IS, Myhr KM, Berge T, Harbo HF, Torkildsen Ø, Holmøy T, Celius EG, Munthe LA, Vaage JT, Lund-Johansen F, Nygaard GO. Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
Øvrige publikasjoner:
M König, AR Lorentzen HMTorgauten et al.
ePoster Humoral Immunity to SARS-COV-2 mRNA Vaccination in patients with multiple sclerosis using High-efficacy disease modifying therapies ECTRIMS e-poster
HM Torgauten et al. Humoral immune response to SARS-CoV-2 vaccination in MS patients treated with rituximab Multiple Sclerosis Journal 2021; 27: (2S) 3–133.
Lie, IA et al. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis Multiple Sclerosis Journal 2021; 27: (2S) 3–133.
Eid, K et al. Childhood abuse and the risk of MS. A population-based cohort study
Multiple Sclerosis Journal 2021; 27: (2S) 3–133.
A. Kapali, M. Cortese, T. Riise, K.-M. Myhr et al. Population-based prospective study of delivery mode and the risk for adult-onset multiple sclerosis Multiple Sclerosis Journal 2021; 27: (2S) 3–133
G.O. Nygaard, H. Torgauten, L. Skattebøl, E.A. Høgestøl, P. Sowa, K.-M. Myhr, Ø.F. Torkildsen, E.G. Celius Disease activity in multiple sclerosis patients switching from fingolimod to cladribine compared to rituximab Multiple Sclerosis Journal 2021; 27: (2S) 3–133.
Norborg, T. Riise, K.-M. Myhr, N. Grytten, S. Wergeland Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis Multiple Sclerosis Journal 2021; 27: (2S) 3–133.
S. Kvistad, J. Burman, L. Bø, A.K. Lehmann, G.K. Melve, A. Tolf, C. Zhukovsky, Ø. Torkildsen The impact of previous disease-modifying treatment for HSCT outcome and the risk of new disease activity in MS Multiple Sclerosis Journal 2021; 27: (2S) 3–133
2020
Skorve E, Lundervold AJ, Torkildsen Ø, Myhr KM
A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS. Mult Scler Relat Disord 2020 Nov;46():102577. Epub 2020 okt 12 PMID:33296975
Kvalvik SA, Skarstein I, Veddeng A, Løland von Volkmann H, Kvalvik T, Torkildsen ØFG, Ebbing C. An immunocompromised woman in her twenties with abdominal pain and vaginal discharge. Tidsskr Nor Laegeforen 2020 Nov 10;140(16). Epub 2020 nov 9 PMID:
33172234
Torkildsen Ø, Myhr KM, Skogen V, Steffensen LH, Bjørnevik K
Tenofovir as a treatment option for multiple sclerosis. Mult Scler Relat Disord 2020 Nov;46():102569. Epub 2020 okt 7 PMID: 33049462
Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. J Neurol 2020 Oct 03. Epub 2020 okt 3 PMID: 33011853
Holmøy T, Torkildsen Ø, Bø L
Treatment of multiple sclerosis under the COVID-19 pandemic. Tidsskr Nor Laegeforen 2020 05 26;140(8). Epub 2020 apr 29 PMID: 32463200
Røsjø E, Lindstrøm JC, Holmøy T, Myhr KM, Varhaug KN, Torkildsen Ø
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. Front Neurol 2020;11():329. Epub 2020 apr 30 PMID: 32425877
Kvistad SAS, Lehmann AK, Trovik LH, Kristoffersen EK, Bø L, Myhr KM, Torkildsen Ø
Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Mult Scler 2020 Dec;26(14):1889-1897. Epub 2019 des 13 PMID:
31833798
Nystad AE, Lereim RR, Wergeland S, Oveland E, Myhr KM, Bø L, Torkildsen Ø
Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. J Neuroimmunol 2020 02 15;339():577091. Epub 2019 okt 31 PMID: 31739156
Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø
Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. Mult Scler 2020 10;26(12):1569-1580. Epub 2019 okt 1 PMID:
31573834
Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB
Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry. Mult Scler Relat Disord 2020 Dec 21;48():102691. Epub 2020 des 21 PMID: 33360174
Bringeland GH, Blaser N, Myhr KM, Vedeler CA, Gavasso S
Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy. Neurol Neuroimmunol Neuroinflamm 2020 05 04;7(3). Epub 2020 feb 4 PMID: 32019768
Bringeland GH, Myhr KM, Vedeler CA, Gavasso S
Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. J Neurol Sci 2020 08 15;415():116880. Epub 2020 mai 5 PMID: 32413799
Kalron A, Ehling R, Baert I, Smedal T, Rasova K, Heric-Mansrud A, Elorriage I, Nedeljkovic U, Tachino A, Gargul L, Gusowski K, Cattaneo D, Borgers S, Hebert J, Dalgas U, Feys P
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study. Mult Scler Relat Disord 2020 Nov;46():102511. Epub 2020 sep 14 PMID: 32949848
Rasová K, Martinková P, Soler B, Freeman J, Cattaneo D, Jonsdottir J, Smedal T, Romberg A, Henze T, Santoyo-Medina C, Feys P
Real-World Goal Setting and Use of Outcome Measures According to the International Classification of Functioning, Disability and Health: A European Survey of Physical Therapy Practice in Multiple Sclerosis. Int J Environ Res Public Health 2020 07 02;17(13). Epub 2020 jul 2 PMID: 32630765
Rasová K, Freeman J, Cattaneo D, Jonsdottir J, Baert I, Smedal T, Romberg A, Feys P, Alves-Guerreiro J, Habek M, Henze T, Santoyo-Medina C, Beiske A, Asch PV, Bakalidou D, Salci Y, Dimitrova E, Pavlíková M, Štetkárová I, Vorlícková J, Martinková P
Content and Delivery of Physical Therapy in Multiple Sclerosis across Europe: A Survey. Int J Environ Res Public Health 2020 01 31;17(3). Epub 2020 jan 31 PMID: 32023868
Smedal T, Gjelsvik BEB What is physiotherapy and where are we heading? Physiother Res Int 2020 01;25(1):e1805. Epub 2019 aug 19 PMID: 31429181
Hakkarainen KM, Juuti R, Burkill S, Geissbühler Y, Sabidó M, Popescu C, Suzart-Woischnik K, Hillert J, Artama M, Verkkoniemi-Ahola A, Myhr KM, Mehtälä J, Bahmanyar S, Montgomery S, Korhonen P Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden. Ther Adv Neurol Disord 2020;13():1756286420951072. Epub 2020 okt 7 PMID: 33101459
Vermersch P, Oh J, Cascione M, Oreja-Guevara C, Gobbi C, Travis LH, Myhr KM, Coyle PK
Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS. Mult Scler Relat Disord 2020 Aug;43():102158. Epub 2020 mai 13 PMID: 32470857
Cortese M, Munger KL, Martínez-Lapiscina EH, Barro C, Edan G, Freedman MS, Hartung HP, Montalbán X, Foley FW, Penner IK, Hemmer B, Fox EJ, Schippling S, Wicklein EM, Kappos L, Kuhle J, Ascherio A, Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT. Neurology 2020 05 05;94(18):e1950-e1960. Epub 2020 apr 16 PMID: 32300060
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S, Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP). J Neurol Neurosurg Psychiatry 2020 06;91(6):660-668. Epub 2020 mar 31 PMID: 32234967
Willumsen JS, Aarseth JH, Myhr KM, Midgard R
High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018. Neurol Neuroimmunol Neuroinflamm 2020 05;7(3). Epub 2020 mar 26 PMID: 32217642
Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Bergsland N, Farbu E
Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Mult Scler J Exp Transl Clin 2020 Jan-Mar;6(1):2055217320902481. Epub 2020 jan 27 PMID: 32064116
International Multiple Sclerosis Genetics Consortium.Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell 2020 Jan 23;180(2):40 3. PMID: 31978348
Myhr KM, Torkildsen Ø
Serum NFL levels should be used to monitor multiple sclerosis evolution - No. Mult Scler 2020 01;26(1):19-21. Epub 2019 okt 18 PMID: 31625829
Utfyllende informasjon
K. Wesnes. https://doi.org/10.1177/1352458520974937
K. Wesnes
The impact of seasonal fluctuations of vitamin D on long-term disability progression in MS
MSVirtual 2020 – Poster Abstracts. Multiple Sclerosis Journal. 2020;26(3_suppl):118-659
Eid, K et al.
Peripartum depression and anxiety in women with ms. A population-based cohort study
MULTIPLE SCLEROSIS JOURNAL Volume: 26 Issue: 3_SUPPL Pages: 651-652 Supplement: 3_ Meeting Abstract: P1129
2019
Bringeland GH, Bader L, Blaser N, Budzinski L, Schulz AR, Mei HE, Myhr KM, Vedeler CA, Gavasso S
Optimization of Receptor Occupancy Assays in Mass Cytometry: Standardization Across Channels with QSC Beads. Cytometry A 2019 03;95(3):314-322. Epub 2019 jan 27 PMID: 30688025
Gavasso S, Bringeland GH, Tárnok A
Receptor occupation in the fjords. Cytometry A 2019 Oct;95(10):1044-1045.
PMID: 31617331
Burkill S, Vattulainen P, Geissbuehler Y, Sabido Espin M, Popescu C, Suzart-Woischnik K, Hillert J, Artama M, Verkkoniemi-Ahola A, Myhr KM, Cnattingius S, Korhonen P, Montgomery S, Bahmanyar S
The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis. PLoS One 2019;14(12):e0227120. Epub 2019 des 30 PMID: 31887199
Kvistad SAS, Lehmann AK, Trovik LH, Kristoffersen EK, Bø L, Myhr KM, Torkildsen Ø
Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Mult Scler 2019 Dec 13. Epub 2019 des 13 PMID: 31833798
Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB
Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. Brain Behav 2019 Nov;9(11):e01422. Epub 2019 okt 4 PMID: 31583850
Skorve E, Lundervold AJ, Torkildsen Ø, Myhr KM
The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler Relat Disord 2019 Nov;36():101408. Epub 2019 sep 21 PMID: 31610403
Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø
Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. Mult Scler 2019 Oct 01. Epub 2019 okt 1 PMID:31573834
International Multiple Sclerosis Genetics Consortium.
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell 2019 Jun 27;178(1):262. PMID: 31251915
Varhaug KN, Torkildsen Ø, Myhr KM, Vedeler CA
Neurofilament Light Chain as a Biomarker in Multiple Sclerosis.
Front Neurol 2019;10():338. Epub 2019 apr 5 PMID: 31024432
Glaser A, Stahmann A, Meissner T, Flachenecker P, Horáková D, Zaratin P, Brichetto G, Pugliatti M, Rienhoff O, Vukusic S, de Giacomoni AC, Battaglia MA, Brola W, Butzkueven H, Casey R, Drulovic J, Eichstädt K, Hellwig K, Iaffaldano P, Ioannidou E, Kuhle J, Lycke K, Magyari M, Malbaša T, Middleton R, Myhr KM, Notas K, Orologas A, Otero-Romero S, Pekmezovic T, Sastre-Garriga J, Seeldrayers P, Soilu-Hänninen M, Stawiarz L, Trojano M, Ziemssen T, Hillert J, Thalheim C
Multiple sclerosis registries in Europe - An updated mapping survey.
Mult Scler Relat Disord 2019 01;27():171-178. Epub 2018 okt 4 PMID: 30384204
Myhr KM, Torkildsen Ø, Lossius A, Bø L, Holmøy T
B cell depletion in the treatment of multiple sclerosis. Expert Opin Biol Ther 2019 03;19(3):261-271. Epub 2019 jan 23 PMID: 30632834
Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients. Mult Scler 2019 06;25(7):987-993. Epub 2018 jun 4 PMID:
29862891
Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C
Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study. Int J Epidemiol 2019 08 01;48(4):1073-1082. PMID: 30561654
Storm-Larsen C, Myhr KM, Farbu E, Midgard R, Nyquist K, Broch L, Berg-Hansen P, Buness A, Holm K, Ueland T, Fallang LE, Burum-Auensen E, Hov JR, Holmøy T
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial.
Mult Scler J Exp Transl Clin 2019 Oct-Dec;5(4):2055217319888767. Epub 2019 nov 15 PMID: 31798939
Bergmann Ø, Henriques R, Westin CF, Pasternak O
Fast and accurate initialization of the free-water imaging model parameters from multi-shell diffusion MRI. NMR Biomed 2019 Dec 19. Epub 2019 des 19 PMID: 31856383
Smolders J, Torkildsen Ø, Camu W, Holmøy T
An Update on Vitamin D and Disease Activity in Multiple Sclerosis.
CNS Drugs 2019 Dec;33(12):1187-1199. PMID: 31686407
Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G
International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler 2019 Nov;25(13):1809-1818. Epub 2018 nov 1 PMID: 30381987
Hoff JM, Dhayalan M, Midelfart A, Tharaldsen AR, Bø L
Visual dysfunction in multiple sclerosis.
Tidsskr Nor Laegeforen 2019 Aug 20;139(11). Epub 2019 aug 2
PMID:31429247
Kalron A, Feys P, Dalgas U, Smedal T, Freeman J, Romberg A, Conyers H, Elorriaga I, Gebara B, Merilainen J, Heric-Mansrud A, Jensen E, Jones K, Knuts K, Maertens de Noordhout B, Martic A, Normann B, O Eijnde B, Rasoina C, Baert I . Searching for the "Active Ingredients" in Physical Rehabilitation Programs Acrossva K, Santoyo Med Europe, Necessary to Improve Mobility in People With Multiple Sclerosis: A Multicenter Study. Neurorehabil Neural Repair 2019 04;33(4):260-270. Epub 2019 mar 17 PMID: 30880560
Baldin E, Riise T, Mattarozzi K, Gajofatto A, Granella F, Leone M, Lugaresi A, Malagù S, Motti L, Neri W, Pesci I, Santangelo M, Scandellari C, Tola MR, Vignatelli L, Zenesini C, D'Alessandro R. Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis. Neurol Sci 2019 Jan;40(1):75-80. Epub 2018 sep 25 PMID: 30255488
Antonazzo IC, Poluzzi E, Forcesi E, Riise T, Bjornevik K, Baldin E, Muratori L, De Ponti F, Raschi E
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System. Mult Scler 2019 Oct;25(12):1633-1640. Epub 2018 sep 19 PMID: 30230957
Øvrige publikasjoner:
Wesnes K, Bjørnevik K et al
Vitamin D levels predict long-term disability in multiple sclerosis
European Journal of Neurology, vol 26, S1, EPO 3216
N. Grytten, KM Myhr, EG. Celius, E. Benjaminsen, MT. Kampman, R. Midgard, A. Vatne, JH. Aarseth, T. Riise, ØFG. Torkildsen
Cancer risk in Multiple sclerosis patients, siblings, and healthy controls: a prospective, longitudinal cohort study European Journal of Neurology, vol. 26, S1
Baldin, E (Baldin, E.); Daltveit, AK (Daltveit, A. -K.); Riise, T (Riise, T.); Pugliatti, M (Pugliatti, M.)
Breastfeeding and risk of developing multiple sclerosis Eropean Journal of Neurology; Vol 26, SI:
Baldin, E; Zenesini, C; Caniatti, L; Granella, F; Immovilli, P; Lugaresi, A; Malagu, S (Malagu, S.); Montepietra, S; Neri, W; Pasquinelli, M; Pesci,; Poluzzi, E; Pugliatti, M; Riise, T; Salvi, F; Santangelo, M; Sola, P ; Vignatelli, L; D'alessandro, R
Antibiotics use and risk of multiple sclerosis: a case-control study in Emilia-Romagna region, Italy European Jounral of Neurology, Vol 26, SI: 873-874
2018
Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study. Int J Epidemiol 2018 Dec 18. Epub 2018 des 18 PMID: 30561654
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.
Cell 2018 Nov 29;175(6):1679-1687.e7. Epub 2018 okt 18PMID: 30343897
Kvistad SS, Myhr KM, Holmøy T, Benth Jš, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Sagen JV, Torkildsen Ø
Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis. J Neuroimmunol 2018 Oct 15;323():73-77. Epub 2018 jul 24 PMID: 30196837
Bhan A, Jacobsen C, Myhr KM, Dalen I, Lode K, Farbu E
Neurofilaments and 10-year follow-up in multiple sclerosis. Mult Scler 2018 Sep;24(10):1301-1307. Epub 2018 aug 1 PMID: 30066611
Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients. Mult Scler 2018 May 01. Epub 2018 mai 1 PMID: 29862891
Svendsen B, Grytten N, Bø L, Aarseth H, Smedal T, Myhr KM
The economic impact of multiple sclerosis to the patients and their families in Norway. Eur J Health Econ 2018 Dec;19(9):1243-1257. Epub 2018 apr 21 PMID: 29680926
Varhaug KN, Barro C, Bjørnevik K, Myhr KM, Torkildsen Ø, Wergeland S, Bindoff LA, Kuhle J, Vedeler C
Neurofilament light chain predicts disease activity in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm 2018 Jan;5(1):e422. Epub 2017 nov 28 PMID: 29209636
Torkildsen Ø, Holmøy T, Myhr KM
Severe multiple sclerosis reactivation after gonadotropin treatment. Mult Scler Relat Disord 2018 May;22():38-40. Epub 2018 mar 6 PMID: 29525298
Olberg HK, Eide GE, Cox RJ, Jul-Larsen Å, Lartey SL, Vedeler CA, Myhr KM
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. Eur J Neurol 2018 03;25(3):527-534. Epub 2018 jan 6 PMID: 29205701
Oveland E, Nystad A, Berven F, Myhr KM, Torkildsen Ø, Wergeland S
1,25-Dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving calcium proteins. Neurochem Int 2018 01;112():267-277. Epub 2017 aug 14 PMID: 28818673
Cortese M, Riise T, Bjørnevik K, Myhr KM,
Body size and physical exercise, and the risk of multiple sclerosis. Mult Scler 2018 Mar;24(3):270-278. Epub 2017 mar 13 PMID: 28287051
Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K
Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study. Mult Scler 2018 Feb;24(2):150-157. Epub 2017 feb 1 PMID: 28273774
Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G
International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler 2018 Nov 01. Epub 2018 nov 1¨PMID: 30381987
Lie IA, Blomberg B, Power ØA, Torkildsen Ø
A man in his twenties with dizziness, double vision and peripheral facial palsy. Tidsskr Nor Laegeforen 2018 10 02;138(15). Epub 2018 sep 26 PMID: 30277051
Wergeland S, Riise T, Torkildsen Ø
Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients' Eur J Neurol 2018 09;25(9):e104. PMID: 30134049
Holmøy T, Torkildsen Ø, Zarnovicky S
Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab. Case Rep Neurol Med 2018;2018():5190794. Epub 2018 jul 19 PMID: 30112230
Nystad AE, Torkildsen Ø, Wergeland S
Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model. J Neuroimmunol 2018 Aug 15;321():61-65. Epub 2018 jun 1 PMID: 29957389
Martinková P, Freeman J, Drabinová A, Erosheva E, Cattaneo D, Jonsdottir J, Baert I, Smedal T, Romberg A, Feys P, Alves-Guerreiro J, Habek M, Henze T, Medina CS, Beiske A, Van Asch P, Bakalidou D, Salci Y, Dimitrova EN, Pavlíková M, Rasová K
Physiotherapeutic interventions in multiple sclerosis across Europe: Regions and other factors that matter. Mult Scler Relat Disord 2018 May;22():59-67. Epub 2018 mar 14 PMID: 29579644
Baert I, Smedal T, Kalron A, Rasova K, Heric-Mansrud A, Ehling R, Elorriaga Minguez I, Nedeljkovic U, Tacchino A, Hellinckx P, Adriaenssens G, Stachowiak G, Gusowski K, Cattaneo D, Borgers S, Hebert J, Dalgas U, Feys P
Responsiveness and meaningful improvement of mobility measures following MS rehabilitation. Neurology 2018 Nov 13;91(20):e1880-e1892. Epub 2018 okt 17 PMID: 30333161
Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K
Urate and the risk of Parkinson's disease in men and women Parkinsonism Relat Disord 2018 Jul;52():76-82. Epub 2018 mar 28 PMID: 29615298
Rotstein DL, Cortese M, Fung TT, Chitnis T, Ascherio A, Munger KL
Diet quality and risk of multiple sclerosis in two cohorts of US women. Mult Scler 2018 Oct 23. Epub 2018 okt 23 PMID: 30351179
Wilcox AJ, Cortese M, Baravelli CM, Skjaerven R
When Intuition Invites the Analytical Mind to Dance-The Essential Role of Creativity in Science Epidemiology 2018 11;29(6):753-755. PMID: 30074539
Antonazzo IC, Poluzzi E, Forcesi E, Riise T, Bjornevik K, Baldin E, Muratori L, De Ponti F, Raschi E
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System. Mult Scler 2018 Sep 19. Epub 2018 sep 19 PMID: 30230957
Antonazzo IC, Raschi E, Forcesi E, Riise T, Bjornevik K, Baldin E, De Ponti F, Poluzzi E
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System. Expert Opin Drug Saf 2018 Sep;17(9):869-874. Epub 2018 aug 11 PMID: 30058390
Bjornevik K, O'Reilly ÉJ, Berry JD, Clish CB, Jeanfavre S, Kato I, Kolonel LN, Le Marchand L, McCullough ML, Paganoni S, Schwarzschild MA, Talbott EO, Wallace RB, Zhang Z, Manson JE, Ascherio A
Prediagnostic plasma branched chain amino acids and the risk of amyotrophic lateral sclerosis Neurology 2018 Nov 14. Epub 2018 nov 14 PMID: 30429276
Myhr KM Tid for en mer offensiv behandlingsstrategi ved multippel sklerose?
BestPractice – Psykiatri/Nevrologi 2018; Årgang 9-Nr.36: 6-7.
Liv Solfrid Bergen, Torild Mauseth, Anne Britt Skår Gruppetilbud til ungdom som pårørende ved mulippel sklerose.
Best Practice Psykiatri/nevrologi, nr 35, september 2018, 9.årgang.
2017
Grytten N
Survival in multiple sclerosis: things have changed. J Neurol Neurosurg Psychiatry 2017 Aug;88(8):618. PMID: 28705950
Lunde HMB, Assmus J, Myhr KM, Bø L, Grytten N
Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study. J Neurol Neurosurg Psychiatry 2017 Aug;88(8):621-625. Epub 2017 apr 1 PMID: 28365589
Grytten N, Skår AB, Aarseth JH, Assmus J, Farbu E, Lode K, Nyland HI, Smedal T, Myhr KM
The influence of coping styles on long-term employment in multiple sclerosis: A prospective study. Mult Scler 2017 Jun;23(7):1008-1017. Epub 2016 sep 6 PMID: 27600114
Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study. Mult Scler 2017 Feb;23(2):213-219. Epub 2016 jul 11. PMID: 27207453
Holmøy T, Torkildsen Ø, Myhr KM
An update on cladribine for relapsing-remitting multiple sclerosis. Expert Opin Pharmacother 2017 Oct;18(15):1627-1635. Epub 2017 sep 11 PMID: 28858531
Guldbrandsen A, Farag Y, Kroksveen AC, Oveland E, Lereim RR, Opsahl JA, Myhr KM, Berven FS, Barsnes H
CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders. Mol Cell Proteomics 2017 Feb;16(2):300-309. Epub 2016 nov 27 PMID: 27890865
Kroksveen AC, Guldbrandsen A, Vaudel M, Lereim RR, Barsnes H, Myhr KM, Torkildsen Ø, Berven FS
In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis. J Proteome Res 2017 Jan 06;16(1):179-194. Epub 2016 okt 26 PMID: 27728768
Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis. Mult Scler 2017 Mar;23(3):395-402. Epub 2016 jul 11 PMID: 27325604
Olberg HK, Eide GE, Cox RJ, Jul-Larsen Å, Lartey SL, Vedeler CA, Myhr KM
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. Eur J Neurol 2017 Dec 04. Epub 2017 des 4 PMID: 29205701
Myhr KM, Mäurer M, Ginés MM, Esposito F, Linker R
Break-out session highlights. Neurodegener Dis Manag 2017 Nov;7(6s):45-49. PMID: 29143586
Benjaminsen E, Myhr KM, Alstadhaug KB
The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway. Seizure 2017 Nov;52():131-135. Epub 2017 okt 6 PMID: 29031194
Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A,
Sodium intake and multiple sclerosis activity and progression in BENEFIT. Ann Neurol 2017 Jul;82(1):20-29. PMID: 28556498
Cortese M, Riise T, Bjørnevik K, Myhr KM,
Body size and physical exercise, and the risk of multiple sclerosis. Mult Scler 2017 Mar 01. Epub 2017 mar 1PMID: 28287051
Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K
Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study. Mult Scler 2017 Feb 01. Epub 2017 feb 1PMID: 28273774
Varhaug KN, Vedeler CA, Myhr KM, Aarseth JH, Tzoulis C, Bindoff LA
Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis.Mitochondrion 2017 May;34():32-35. Epub 2016 des 23PMID: 28017684
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L,
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.N Engl J Med 2017 01 19;376(3):221-234. Epub 2016 des 21PMID: 28002679
Berger T, Elovaara I, Fredrikson S, McGuigan C, Moiola L, Myhr KM, Oreja-Guevara C, Stoliarov I, Zettl UK
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts.CNS Drugs 2017 Jan;31(1):33-50. PMID: 27882532
Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.Mult Scler 2017 Jun;23(7):1018-1024. Epub 2016 sep 23PMID: 27663872
Alstadhaug KB, Myhr KM, Rinaldo CH
Progressive multifocal leukoencephalopathy.Tidsskr Nor Laegeforen 2017 12 12;137(23-24). Epub 2017 des 12PMID: 29231623
Cortese M, Yuan C, Chitnis T, Ascherio A, Munger KL
No association between dietary sodium intake and the risk of multiple sclerosis.Neurology 2017 Sep 26;89(13):1322-1329. Epub 2017 aug 25PMID: 28842447
Bjørnevik K, Chitnis T, Ascherio A, Munger KL
Polyunsaturated fatty acids and the risk of multiple sclerosis.Mult Scler 2017 Dec;23(14):1830-1838. Epub 2017 feb 3PMID: 28156186
Amato MP, Derfuss T, Hemmer B, Liblau R, Montalban X, Soelberg Sørensen P, Miller DH,
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.Mult Scler 2017 01 06. Epub 2017 jan 6PMID: 28671487
Antonazzo IC, Raschi E, Vignatelli L, Baldin E, Riise T, D'Alessandro R, De Ponti F, Poluzzi E
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.Drug Saf 2017 Sep;40(9):823-834. PMID: 28597251
Mittal S, Bjørnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Schüle B, Park DS, Riise T, Scherzer CR
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.Science 2017 09 01;357(6354):891-898.PMID: 28860381
Olafsson S ... Myhr K-M...et al.
Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlationsNPJ GENOMIC MEDICINE Volume: 2 Article Number: 24 Published AUG 8 2017
Haugstad R
MS-sykepleierfunksjonen i endring
Bestpractice. Nr 32, November 2017 8. årgang
Grytten Torkildsen N, Myhr K-M
Mestringsstrategien påvirker risikoen for uførhet ved MS
Bestpractice. Nr. 29, februar 2017, 8. årgang
Guldbrandsen A, Vaudel M, Barsnes H
Fremtiden for biomedisinsk forskning - store endringer gir nye muligheter
Bestpractice. Nr. 29, februar 2017, 8. årgang
Myhr KM
Tid for taktskifte i sykdomsmodulerende MS- behandling
Bestpractice, Nr. 30, april, 8. årgang
Myhr KM
B- cellemodulering ved behandling av multippel sklerose
Bestpractice, Nr. 30, april, 8. årgang
Varhaug K, Vedeler CA, Bindoff L
Økt cellefritt mitokondrie-DNA i spinalvæsken til MS pasienter - jakten etter MS- biomarkører.
Bestpractice, Nr. 31, september, årgang 8
Lereim RL, Oveland Eystein, Myhr K-M
peli1 i immunregulering ved multippel sklerose
Bestpractice, Nr. 31, september, årgang 8
2016
Grytten N, Skår AB, Aarseth JH, Assmus J, Farbu E, Lode K, Nyland HI, Smedal T, Myhr KM The influence of coping styles on long-term employment in multiple sclerosis: A prospective study. Mult Scler 2016 Sep 06. Epub 2016 sep 6 PMID: 27600114
Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, HogenEsch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom. Ann Neurol 2016 Oct;80(4):616-24.
PMID: 27554176
Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study. Mult Scler 2016 May 05. Epub 2016 mai 5 PMID: 27207453
Grytten N, Aarseth JH, Lunde HM, Myhr KM
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway. J Neurol Neurosurg Psychiatry 2016 Jan;87(1):100-5. Epub 2015 feb 24 PMID: 25714916
Varhaug KN, Vedeler CA, Myhr KM, Aarseth JH, Tzoulis C, Bindoff LA
Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. Mitochondrion 2016 Dec 23. Epub 2016 des 23 PMID: 28017684
Guldbrandsen A, Farag Y, Kroksveen AC, Oveland E, Lereim RR, Opsahl JA, Myhr KM, Berven FS, Barsnes H
CSF-PR 2.0: an interactive literature guide to quantitative cerebrospinal fluid mass spectrometry data from neurodegenerative disorders. Mol Cell Proteomics 2016 Nov 27. Epub 2016 nov 27 PMID: 27890865
Berger T, Elovaara I, Fredrikson S, McGuigan C, Moiola L, Myhr KM, Oreja-Guevara C, Stoliarov I, Zettl UK
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts. CNS Drugs 2016 Nov 23. Epub 2016 nov 23 PMID: 27882532
Lereim RR, Oveland E, Xiao Y, Torkildsen Ø, Wergeland S, Myhr KM, Sun SC, Berven FS The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis.
J Proteomics Bioinform 2016 Sep;9(9):209-219. Epub 2016 sep 12 PMID: 27746629
Kroksveen AC, Guldbrandsen A, Vaudel M, Lereim RR, Barsnes H, Myhr KM, Torkildsen Ø, Berven FS In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis; presenting a comprehensive picture of pathways and processes affected by multiple sclerosis.
J Proteome Res 2016 Oct 11. Epub 2016 okt 11 PMID: 27728768
Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study. Mult Scler 2016 Sep 23. Epub 2016 sep 23
Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM,
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology 2016 Sep 06;87(10):978-87. Epub 2016 aug 10 PMID: 27511182
Kvistad S, Myhr KM, Holmøy T, Benth Jš, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø No association of tobacco use and disease activity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2016 Aug;3(4):e260. Epub 2016 jul 14 PMID: 27458599
Keshari PK, Harbo HF, Myhr KM, Aarseth JH, Bos SD, Berge T
Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood. BMC Genet 2016 Apr 14;17():59. Epub 2016 apr 14 PMID: 27080863
Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients. Eur J Neurol 2016 Jun;23(6):1064-70. Epub 2016 mar 21 PMID: 26998820
Opsahl JA, Vaudel M, Guldbrandsen A, Aasebø E, van Pesch V, Franciotta D, Myhr KM, Barsnes H, Berle M, Torkildsen Ø, Kroksveen AC, Berven FS
Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Proteomics 2016 Apr;16(7):1154-65. PMID: 26841090
Torkildsen Ø, Myhr KM, Bø L
Disease-modifying treatments for multiple sclerosis - a review of approved medications. Eur J Neurol 2016 Jan;23 Suppl 1():18-27. PMID: 26563094
Goulden R, Riise T, Myhr KM, Pugliatti M, Wolfson C
Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study. Eur J Neurol 2016 Jan;23(1):168-74. Epub 2015 okt 16 PMID: 26475404
Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltyte-Benth J, Hovdal H, Myhr KM
WT1 and interferon-ß-vitamin D association in MS: a longitudinal study. Acta Neurol Scand 2016 Apr;133(4):309-12. Epub 2015 jun 2 PMID: 26037530
Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study. Mult Scler 2016 Jan;22(1):104-11. Epub 2015 mai 26 PMID: 26014605
Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, Evdoshenko E, Thouvenot E, Trojano M, Norgren N, Teunissen C, Kappos L, Giovannoni G, Kuhle J,
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2016 Feb;87(2):126-9. Epub 2015 feb 25 PMID: 25716934
Vaudel M, Barsnes H, Ræder H, Berven FS
Using Proteomics Bioinformatics Tools and Resources in Proteogenomic Studies. Adv Exp Med Biol 2016;926():65-75. PMID: 27686806
Hernández Sánchez LF, Aasebø E, Selheim F, Berven FS, Ræder H, Barsnes H, Vaudel M Systemic Analysis of Regulated Functional Networks.
Methods Mol Biol 2016;1394():287-310. PMID: 26700057
Guldbrandsen A, Barsnes H, Kroksveen AC, Berven FS, Vaudel M
A Simple Workflow for Large Scale Shotgun Glycoproteomics. Methods Mol Biol 2016;1394():275-86. PMID: 26700056
Aasebø E, Berven FS, Selheim F, Barsnes H, Vaudel M
Interpretation of Quantitative Shotgun Proteomic Data. Methods Mol Biol 2016;1394():261-73. PMID: 26700055
Vaudel M, Verheggen K, Csordas A, Raeder H, Berven FS, Martens L, Vizcaíno JA, Barsnes H
Exploring the potential of public proteomics data. Proteomics 2016 Jan;16(2):214-25. Epub 2015 des 15 PMID: 26449181
Vaudel M, Barsnes H, Bjerkvig R, Bikfalvi A, Selheim F, Berven FS, Daubon T
Practical Considerations for Omics Experiments in Biomedical Sciences. Curr Pharm Biotechnol 2016;17(1):105-14. PMID: 26278526
Holmøy T, Torkildsen Ø
Family planning, pregnancy and breastfeeding in multiple sclerosis. Tidsskr Nor Laegeforen 2016 Nov;136(20):1726-1729. Epub 2016 nov 8 PMID: 27830907
Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis. Mult Scler 2016 Jun 20. Epub 2016 jun 20 PMID: 27325604
Lunde HM, Torkildsen Ø, Bø L, Bertelsen AK
Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia. Headache 2016 Jun;56(6):1035-9. Epub 2016 mar 17 PMID: 26992044
Torkildsen Ø, Power Ø, Storstein A
Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis. BMJ Case Rep 2016 Feb 23;2016(). Epub 2016 feb 23 PMID: 26907823
Holmøy T, Torkildsen Ø
Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis? Expert Rev Neurother 2016;16(3):233-5. Epub 2016 feb 12 PMID: 26796244
Rasova K, Freeman J, Martinkova P, Pavlikova M, Cattaneo D, Jonsdottir J, Henze T, Baert I, Van Asch P, Santoyo C, Smedal T, Beiske AG, Stachowiak M, Kovalewski M, Nedeljkovic U, Bakalidou D, Guerreiro JM, Nilsagård Y, Dimitrova EN, Habek M, Armutlu K, Donzé C, Ross E, Ilie AM, Martic A, Romberg A, Feys P
The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey. BMC Health Serv Res 2016 Oct 06;16(1):552. Epub 2016 okt 6 PMID: 27716390
Grant WB, Riise T
Multiple sclerosis: A lifestyle disease? Neurology 2016 Mar 09. Epub 2016 mar 9 PMID: 26962071
Skår, ABR
ABR Skår. Attakktelefon for pasienter med multippel sklerose - som en del av pasientforløpet.
BestPractice Psykiatri/ Nevrologi2016:26;12
Myhr, KM
En tidlig oppstart og aktiv justering av behandlingen er viktig for optimal MS omsorg.
BestPractice Psykiatri/ Nevrologi 2016;26:8
Cortese, M et al.
Sykdomsaktivitet før første symptom ved MS .
BestPractice Psykiatri/ Nevrologi 2016;28:10-14
Mauseth, T
T Mauseth. Unges erfaringer når mor eller far har multippel sklerose.
BestPractice Psykiatri/ Nevrologi 2016:26;18.
Svendsen, B
Kostnaden ved MS i Norge - hva pasientene og familiene deres må betale.
BestPractice Psykiatri/ Nevrologi 2016:26;10
Wesnes, K
Overvekt - en risiko for MS?
BestPractice Psykiatri/ Nevrologi 2016:26;16
2015
Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study. Mult Scler 2015 Dec;21(14):1856-64. Epub 2015 mai 6 PMID: 25948625
Grytten N, Torkildsen Ø, Myhr KM
Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'. Acta Neurol Scand 2015 Nov;132(5):368-9. Epub 2015 sep 15 PMID: 26369381
Grytten N, Torkildsen Ø, Myhr KM
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. Acta Neurol Scand 2015;132(199):29-36. PMID: 26046556
Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH
The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurol Scand 2015;132(199):24-8. PMID: 26046555
Kroksveen AC, Jaffe JD, Aasebø E, Barsnes H, Bjørlykke Y, Franciotta D, Keshishian H, Myhr KM, Opsahl JA, van Pesch V, Teunissen CE, Torkildsen Ø, Ulvik RJ, Vethe H, Carr SA, Berven FS
Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics 2015 Oct;15(19):3361-9. Epub 2015 sep 8 PMID: 26152395
Kroksveen AC, Opsahl JA, Guldbrandsen A, Myhr KM, Oveland E, Torkildsen Ø, Berven FS
Cerebrospinal fluid proteomics in multiple sclerosis. Biochim Biophys Acta 2015 Jul;1854(7):746-56. Epub 2014 des 16 PMID: 25526888
Vaudel M, Verheggen K, Csordas A, Raeder H, Berven FS, Martens L, Vizcaíno JA, Barsnes H
Exploring the potential of public proteomics data. Proteomics 2015 Oct 9. Epub 2015 okt 9 PMID: 26449181
Horvatovich P, Végvári Á, Saul J, Park JG, Qiu J, Syring M, Pirrotte P, Petritis K, Tegeler TJ, Aziz M, Fuentes M, Diez P, Gonzalez-Gonzalez M, Ibarrola N, Droste C, De Las Rivas J, Gil C, Clemente F, Hernaez ML, Corrales FJ, Nilsson CL, Berven FS, Bischoff R, Fehniger TE, LaBaer J, Marko-Varga G
In Vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins. J Proteome Res 2015 Sep 4;14(9):3441-51. Epub 2015 jul 28 PMID: 26155874
Wang X, Zhang Y, Nilsson CL, Berven FS, Andrén PE, Carlsohn E, Horvatovich P, Malm J, Fuentes M, Végvári Á, Welinder C, Fehniger TE, Rezeli M, Edula G, Hober S, Nishimura T, Marko-Varga G
Association of chromosome 19 to lung cancer genotypes and phenotypes. Cancer Metastasis Rev 2015 Jun;34(2):217-26. PMID: 25982285
Vaudel M, Burkhart JM, Zahedi RP, Oveland E, Berven FS, Sickmann A, Martens L, Barsnes H
PeptideShaker enables reanalysis of MS-derived proteomics data sets. Nat Biotechnol 2015 Jan;33(1):22-4. PMID: 25574629
Farag Y, Berven FS, Jonassen I, Petersen K, Barsnes H
Distributed and interactive visual analysis of omics data. J Proteomics 2015 Nov 3;129():78-82. Epub 2015 jun 3 PMID: 26047716
Oveland E, Muth T, Rapp E, Martens L, Berven FS, Barsnes H
Viewing the proteome: how to visualize proteomics data? Proteomics 2015 Apr;15(8):1341-55. Epub 2015 jan 21 PMID: 25504833
Bjorlykke Y, Vethe H, Vaudel M, Barsnes H, Berven FS, Tjora E, Raeder H
Carboxyl-ester lipase maturity-onset diabetes of the young disease protein biomarkers in secretin-stimulated duodenal juice. J Proteome Res 2015 Jan 2;14(1):521-30. Epub 2014 nov 4 PMID: 25369532
Nilsson CL, Mostovenko E, Lichti CF, Ruggles K, Fenyö D, Rosenbloom KR, Hancock WS, Paik YK, Omenn GS, LaBaer J, Kroes RA, Uhlén M, Hober S, Végvári Á, Andrén PE, Sulman EP, Lang FF, Fuentes M, Carlsohn E, Emmett MR, Moskal JR, Berven FS, Fehniger TE, Marko-Varga G
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. J Proteome Res 2015 Feb 6;14(2):603-8. Epub 2014 nov 26 PMID: 25369122
Kvistad SS, Myhr KM, Holmøy T, Šaltyte Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø
Body mass index influence interferon-beta treatment response in multiple sclerosis. J Neuroimmunol 2015 Nov 15;288():92-7. Epub 2015 sep 26 PMID: 26531700
Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltyte Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis. J Neurol 2015 Dec;262(12):2713-21. Epub 2015 okt 1 PMID: 26429571
Alme MN, Nystad AE, Bø L, Myhr KM, Vedeler CA, Wergeland S, Torkildsen Ø
Fingolimod does not enhance cerebellar remyelination in the cuprizone model. J Neuroimmunol 2015 Aug 15;285():180-6. Epub 2015 jun 19 PMID: 26198937
Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltyte-Benth J, Hovdal H, Myhr KM
WT1 and interferon-ß-vitamin D association in MS: a longitudinal study. Acta Neurol Scand 2015 Jun 2. Epub 2015 jun 2 PMID: 26037530
Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T
Impact of the environment on multiple sclerosis. Tidsskr Nor Laegeforen 2015 May 19;135(9):856-60. Epub 2015 mai 19 PMID: 25991624
Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltyte Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T
Vitamin D status and effect of interferon-ß1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. J Neuroimmunol 2015 Mar 15;280():21-8. Epub 2015 feb 11 PMID: 25773151
Fjær S, Bø L, Myhr KM, Torkildsen Ø, Wergeland S
Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. Neurochem Int 2015 Apr-May;83-84():28-40. Epub 2015 mar 2 PMID: 25744931
Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Dalla Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Mult Scler 2015 Jul;21(8):1013-24. Epub 2015 feb 13 PMID: 25680984
Fazekas F, Gehring K, Gallo P, Lebrun-Frénay C, Moral E, Myhr KM
Country break-out session highlights. Neurodegener Dis Manag 2015 Dec;5(6 Suppl):31-7. PMID: 26611270
Goulden R, Riise T, Myhr KM, Pugliatti M, Wolfson C
Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study. Eur J Neurol 2015 Oct 16. Epub 2015 okt 16 PMID: 26475404
Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C
The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis. Neuroepidemiology 2015;44(3):173-81. Epub 2015 mai 7 PMID: 25967369
Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM, Wolfson C, Pugliatti M
Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. J Neurol 2015 May;262(5):1271-7. Epub 2015 mar 21 PMID: 25794863
Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA, , Sawcer SJ, Andreassen BK, Dubois B, Harbo HF
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain 2015 Mar;138(Pt 3):632-43. Epub 2015 jan 22 PMID: 25616667
Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, Myhr KM, Haugarvoll K, Zetterberg H, Harbo H, Kockum I, Hillert J, Wszolek Z, Rademakers R, Andersen O
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. Eur J Neurol 2015 Feb;22(2):328-33. Epub 2014 okt 13 PMID: 25311247
Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM
Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Mult Scler 2015 Apr;21(4):388-95. Epub 2014 sep 2 PMID: 25182290
Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. Eur J Hum Genet 2015 May;23(5):688-92. Epub 2014 aug 27 PMID: 25159868
Rasova K, Martinkova P, Pavlikova M, Cattaneo D, Jonsdottir J, Henze T, Baert I, Van Asch P, Santoyo C, Smedal T, Beiske AG, Stachowiak M, Kovalewski M, Nedeljkovic U, Bakalidou D, Alves-Guerreiro J, Nilsagard Y, Dimitrova EN, Habek M, Armutlu K, Donzé C, Ross E, Ilie AM, Martic A, Freeman J, Romber A, Feys P
Physical therapy provision in multiple sclerosis across Europe: a regional lottery? Eur J Phys Rehabil Med 2015 Sep 2. Epub 2015 sep 2 PMID: 26334364
2014
Guldbrandsen Astrid, Vethe Heidrun, Farag Yehia, Oveland Eystein, Garberg Hilde, Berle Magnus, Myhr Kjell-Morten, Opsahl Jill A, Barsnes Harald, Berven Frode S
In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). Mol Cell Proteomics 2014 Nov;13(11):3152-63. Epub 2014 jul 18 PMID:25038066
Bjørnevik Kjetil, Riise Trond, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Holmøy Trygve, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Lossius Andreas, Magalhaes Sandra, Myhr Kjell-Morten, Pekmezovic Tatjana, Wesnes Kristin, Wolfson Christina, Pugliatti Maura
Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study. Mult Scler 2014 Jan 10;20(8):1042-1049. Epub 2014 jan 10 PMID: 24414538
Wesnes Kristin, Riise Trond, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Holmøy Trygve, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Lossius Andreas, Magalhaes Sandra, Pekmezovic Tatjana, Bjørnevik Kjetil, Wolfson Christina, Pugliatti Maura, Myhr Kjell-Morten Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study. Mult Scler 2014 Sep 2. Epub 2014 sep 2 PMID: 25182290
Bøe Lunde Hanne Marie, Telstad Wenche, Grytten Nina, Kyte Lars, Aarseth Jan, Myhr Kjell-Morten, Bø Lars Employment among patients with multiple sclerosis-a population study. PLoS One 2014;9(7):e103317. Epub 2014 jul 23 PMID: 25054972
Torkildsen Oivind, Aarseth Jan, Celius Elisabeth Gulowsen, Holmøy Trygve, Kampman Margitta T, Løken-Amsrud Kristin Ingeleiv, Midgard Rune, Myhr Kjell-Morten, Riise Trond, Grytten Nina Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments. Ann Clin Transl Neurol 2014 May;1(5):376-7. Epub 2014 apr 10 PMID: 25356407
Torkildsen Oivind, Aarseth Jan, Benjaminsen Espen, Celius Elisabeth, Holmøy Trygve, Kampman Margitta T, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Riise Trond, Grytten Nina Month of birth and risk of multiple sclerosis: confounding and adjustments. Ann Clin Transl Neurol 2014 Feb;1(2):141-4. Epub 2014 feb 4 PMID: 25356394
Skår Anne Britt Rundhovde, Folkestad Helge, Smedal Tori, Grytten Nina
"I refer to them as my colleagues": the experience of mutual recognition of self, identity and empowerment in multiple sclerosis. Disabil Rehabil 2014;36(8):672-7. Epub 2013 jul 26 PMID: 23889526
Gavasso Sonia, Mosleth Ellen Faergestad, Marøy Tove, Jørgensen Katarina, Nakkestad Hanne-Linda, Gjertsen Bjørn-Tore, Myhr Kjell-Morten, Vedeler Christian
Deficient phosphorylation of Stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta. PLoS One 2014;9(2):e88632. Epub 2014 feb 19 PMID: 24586361
Baert Ilse, Freeman Jennifer, Smedal Tori, Dalgas Ulrik, Romberg Anders, Kalron Alon, Conyers Helen, Elorriaga Iratxe, Gebara Benoit, Gumse Johanna, Heric Adnan, Jensen Ellen, Jones Kari, Knuts Kathy, Maertens de Noordhout Benoît, Martic Andrej, Normann Britt, Eijnde Bert O, Rasova Kamila, Santoyo Medina Carmen, Truyens Veronik, Wens Inez, Feys Peter Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabil Neural Repair 2014 Sep;28(7):621-31. Epub 2014 feb 6 PMID: 24503204
Torkildsen Oivind, Myhr Kjell-Morten, Wergeland Stig
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS. Neurol Neuroimmunol Neuroinflamm 2014 Oct;1(3):e25. Epub 2014 aug 21 PMID: 25340078
Holmøy Trygve, Myhr Kjell-Morten, Bø Lars
[In Process Citation]. Tidsskr Nor Laegeforen 2014 Dec;134(23-24):2239-40. Epub 2014 des 9 PMID: 25492327
Holmøy Trygve, Løken-Amsrud Kristin, Kampman Margitta T, Torkildsen Øivind, Myhr Kjell-Morten [Re: Vitamin D--how much is enough, and is more better for your health?].
Tidsskr Nor Laegeforen 2014 May 27;134(10):1024-5. Epub 2014 mai 27 PMID: 24865723
Kvistad Silje, Myhr Kjell-Morten, Holmøy Trygve, Bakke Søren, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Løken-Amsrud Kristin I, Lilleås Finn, Midgard Rune, Njølstad Gro, Pedersen Tom, Benth Jurate Šaltyte, Wergeland Stig, Torkildsen Oivind
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis. Mult Scler 2014 Dec;20(14):1833-40. Epub 2014 mai 19 PMID: 24842958
Røsjø Egil, Myhr Kjell-Morten, Løken-Amsrud Kristin Ingeleiv, Bakke Søren Jacob, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Torkildsen Øivind, Wergeland Stig, Michelsen Annika E, Aukrust Pål, Ueland Thor, Holmøy Trygve Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. J Neuroimmunol 2014 Jun 15;271(1-2):60-5. Epub 2014 mar 24 PMID: 24713402
Lossius Andreas, Riise Trond, Pugliatti Maura, Bjørnevik Kjetil, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Magalhaes Sandra, Myhr Kjell-Morten, Pekmezovic Tatjana, Wesnes Kristin, Wolfson Christina, Holmøy Trygve Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. Mult Scler 2014 May;20(6):669-74. Epub 2013 sep 26 PMID: 24072723
Kroksveen Ann C, Opsahl Jill A, Guldbrandsen Astrid, Myhr Kjell-Morten, Oveland Eystein, Torkildsen Øivind, Berven Frode S Cerebrospinal fluid proteomics in multiple sclerosis. Biochim Biophys Acta 2014 Dec 16. Epub 2014 des 16 PMID: 25526888
Westerlind Helga, Imrell Kerstin, Ramanujam Ryan, Myhr Kjell-Morten, Celius Elisabeth Gulowsen, Harbo Hanne F, Oturai Annette Bang, Hamsten Anders, Alfredsson Lars, Olsson Tomas, Kockum Ingrid, Koski Timo, Hillert Jan Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. Eur J Hum Genet 2014 Aug 27. Epub 2014 aug 27 PMID: 25159868
Gnanapavan Sharmilee, Hegen Harald, Khalil Michael, Hemmer Bernhard, Franciotta Diego, Hughes Steve, Hintzen Rogier, Jeromin Andreas, Havrdova Eva, Tumani Hayrettin, Bertolotto Antonio, Comabella Manuel, Frederiksen Jette, Álvarez-Cermeño José C, Villar Luisa, Galimberti Daniela, Myhr Kjell-Morten, Dujmovic Irena, Fazekas Franz, Ionete Carolina, Menge Til, Kuhle Jens, Keir Geoffrey, Deisenhammer Florian, Teunissen Charlotte, Giovannoni Gavin Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology 2014 Sep 23;83(13):1210-6. Epub 2014 aug 22 PMID: 25150289
Gustavsen Marte W, Viken Marte K, Celius Elisabeth G, Berge Tone, Mero Inger-Lise, Berg-Hansen Pål, Aarseth Jan H, Myhr Kjell-Morten, Søndergaard Helle B, Sellebjerg Finn, Oturai Annette B, Hillert Jan, Alfredsson Lars, Olsson Tomas, Kockum Ingrid, Lie Benedicte A, Harbo Hanne F Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. J Neuroimmunol 2014 Sep 15;274(1-2):174-9. Epub 2014 jul 6 PMID: 25037176
Nystad Agnes E, Wergeland Stig, Aksnes Lage, Myhr Kjell-Morten, Bø Lars, Torkildsen Oivind Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model. APMIS 2014 Dec;122(12):1178-86. Epub 2014 mai 26 PMID: 24862867
Aasebø Elise, Opsahl Jill Anette, Bjørlykke Yngvild, Myhr Kjell-Morten, Kroksveen Ann Cathrine, Berven Frode S Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. PLoS One 2014;9(3):e90429. Epub 2014 mar 5 PMID: 24599184
Jacobsen Cecilie, Hagemeier Jesper, Myhr Kjell-Morten, Nyland Harald, Lode Kirsten, Bergsland Niels, Ramasamy Deepa P, Dalaker Turi O, Larsen Jan Petter, Farbu Elisabeth, Zivadinov Robert Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. J Neurol Neurosurg Psychiatry 2014 Oct;85(10):1109-15. Epub 2014 feb 19 PMID: 24554101
Olberg Henning K, Cox Rebecca J, Nostbakken Jane K, Aarseth Jan H, Vedeler Christian A, Myhr Kjell-Morten Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Mult Scler 2014 Jan 16;20(8):1074-1080. Epub 2014 jan 16 PMID: 24436455
Thompson Paul M, Stein Jason L, Medland Sarah E, Hibar Derrek P, Vasquez Alejandro Arias, Renteria Miguel E, Toro Roberto, Jahanshad Neda, Schumann Gunter, Franke Barbara, Wright Margaret J, Martin Nicholas G, Agartz Ingrid, Alda Martin, Alhusaini Saud, Almasy Laura, Almeida Jorge, Alpert Kathryn, Andreasen Nancy C, Andreassen Ole A, Apostolova Liana G, Appel Katja, Armstrong Nicola J, Aribisala Benjamin, Bastin Mark E, Bauer Michael, Bearden Carrie E, Bergmann Orjan, Binder Elisabeth B, Blangero John, Bockholt Henry J, Bøen Erlend, Bois Catherine, Boomsma Dorret I, Booth Tom, Bowman Ian J, Bralten Janita, Brouwer Rachel M, Brunner Han G, Brohawn David G, Buckner Randy L, Buitelaar Jan, Bulayeva Kazima, Bustillo Juan R, Calhoun Vince D, Cannon Dara M, Cantor Rita M, Carless Melanie A, Caseras Xavier, Cavalleri Gianpiero L, Chakravarty M Mallar, Chang Kiki D, Ching Christopher R K, Christoforou Andrea, Cichon Sven, Clark Vincent P, Conrod Patricia, Coppola Giovanni, Crespo-Facorro Benedicto, Curran Joanne E, Czisch Michael, Deary Ian J, de Geus Eco J C, den Braber Anouk, Delvecchio Giuseppe, Depondt Chantal, de Haan Lieuwe, de Zubicaray Greig I, Dima Danai, Dimitrova Rali, Djurovic Srdjan, Dong Hongwei, Donohoe Gary, Duggirala Ravindranath, Dyer Thomas D, Ehrlich Stefan, Ekman Carl Johan, Elvsåshagen Torbjørn, Emsell Louise, Erk Susanne, Espeseth Thomas, Fagerness Jesen, Fears Scott, Fedko Iryna, Fernández Guillén, Fisher Simon E, Foroud Tatiana, Fox Peter T, Francks Clyde, Frangou Sophia, Frey Eva Maria, Frodl Thomas, Frouin Vincent, Garavan Hugh, Giddaluru Sudheer, Glahn David C, Godlewska Beata, Goldstein Rita Z, Gollub Randy L, Grabe Hans J, Grimm Oliver, Gruber Oliver, Guadalupe Tulio, Gur Raquel E, Gur Ruben C, Göring Harald H H, Hagenaars Saskia, Hajek Tomas, Hall Geoffrey B, Hall Jeremy, Hardy John, Hartman Catharina A, Hass Johanna, Hatton Sean N, Haukvik Unn K, Hegenscheid Katrin, Heinz Andreas, Hickie Ian B, Ho Beng-Choon, Hoehn David, Hoekstra Pieter J, Hollinshead Marisa, Holmes Avram J, Homuth Georg, Hoogman Martine, Hong L Elliot, Hosten Norbert, Hottenga Jouke-Jan, Hulshoff Pol Hilleke E, Hwang Kristy S, Jack Clifford R, Jenkinson Mark, Johnston Caroline, Jönsson Erik G, Kahn René S, Kasperaviciute Dalia, Kelly Sinead, Kim Sungeun, Kochunov Peter, Koenders Laura, Krämer Bernd, Kwok John B J, Lagopoulos Jim, Laje Gonzalo, Landen Mikael, Landman Bennett A, Lauriello John, Lawrie Stephen M, Lee Phil H, Le Hellard Stephanie, Lemaître Herve, Leonardo Cassandra D, Li Chiang-Shan, Liberg Benny, Liewald David C, Liu Xinmin, Lopez Lorna M, Loth Eva, Lourdusamy Anbarasu, Luciano Michelle, Macciardi Fabio, Machielsen Marise W J, Macqueen Glenda M, Malt Ulrik F, Mandl René, Manoach Dara S, Martinot Jean-Luc, Matarin Mar, Mather Karen A, Mattheisen Manuel, Mattingsdal Morten, Meyer-Lindenberg Andreas, McDonald Colm, McIntosh Andrew M, McMahon Francis J, McMahon Katie L, Meisenzahl Eva, Melle Ingrid, Milaneschi Yuri, Mohnke Sebastian, Montgomery Grant W, Morris Derek W, Moses Eric K, Mueller Bryon A, Muñoz Maniega Susana, Mühleisen Thomas W, Müller-Myhsok Bertram, Mwangi Benson, Nauck Matthias, Nho Kwangsik, Nichols Thomas E, Nilsson Lars-Göran, Nugent Allison C, Nyberg Lars, Olvera Rene L, Oosterlaan Jaap, Ophoff Roel A, Pandolfo Massimo, Papalampropoulou-Tsiridou Melina, Papmeyer Martina, Paus Tomas, Pausova Zdenka, Pearlson Godfrey D, Penninx Brenda W, Peterson Charles P, Pfennig Andrea, Phillips Mary, Pike G Bruce, Poline Jean-Baptiste, Potkin Steven G, Pütz Benno, Ramasamy Adaikalavan, Rasmussen Jerod, Rietschel Marcella, Rijpkema Mark, Risacher Shannon L, Roffman Joshua L, Roiz-Santiañez Roberto, Romanczuk-Seiferth Nina, Rose Emma J, Royle Natalie A, Rujescu Dan, Ryten Mina, Sachdev Perminder S, Salami Alireza, Satterthwaite Theodore D, Savitz Jonathan, Saykin Andrew J, Scanlon Cathy, Schmaal Lianne, Schnack Hugo G, Schork Andrew J, Schulz S Charles, Schür Remmelt, Seidman Larry, Shen Li, Shoemaker Jody M, Simmons Andrew, Sisodiya Sanjay M, Smith Colin, Smoller Jordan W, Soares Jair C, Sponheim Scott R, Sprooten Emma, Starr John M, Steen Vidar M, Strakowski Stephen, Strike Lachlan, Sussmann Jessika, Sämann Philipp G, Teumer Alexander, Toga Arthur W, Tordesillas-Gutierrez Diana, Trabzuni Daniah, Trost Sarah, Turner Jessica, Van den Heuvel Martijn, van der Wee Nic J, van Eijk Kristel, van Erp Theo G M, Van Haren Neeltje E M, van 't Ent Dennis, van Tol Marie-Jose, Valdés Hernández Maria C, Veltman Dick J, Versace Amelia, Völzke Henry, Walker Robert, Walter Henrik, Wang Lei, Wardlaw Joanna M, Weale Michael E, Weiner Michael W, Wen Wei, Westlye Lars T, Whalley Heather C, Whelan Christopher D, White Tonya, Winkler Anderson M, Wittfeld Katharina, Woldehawariat Girma, Wolf Christiane, Zilles David, Zwiers Marcel P, Thalamuthu Anbupalam, Schofield Peter R, Freimer Nelson B, Lawrence Natalia S, Drevets Wayne, Alzheimer's Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study (SYS) Group
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014 Jun;8(2):153-82. PMID: 4399358
Klevan G, Jacobsen C O, Aarseth J H, Myhr K-M, Nyland H, Glad S, Lode K, Figved N, Larsen J P, Farbu E ealth related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurol Scand 2014 Jan;129(1):21-6. Epub 2013 jun 15
PMID:23772958
Flachenecker Peter, Buckow Karoline, Pugliatti Maura, Kes Vanja Bašic, Battaglia Mario A, Boyko Alexey, Confavreux Christian, Ellenberger David, Eskic Danica, Ford David, Friede Tim, Fuge Jan, Glaser Anna, Hillert Jan, Holloway Edward, Ioannidou Eva, Kappos Ludwig, Kasilingam Elisabeth, Koch-Henriksen Nils, Kuhle Jens, Lepore Vito, Middleton Rod, Myhr Kjell-Morton, Orologas Anastasios, Otero Susana, Pitschnau-Michel Dorothea, Rienhoff Otto, Sastre-Garriga Jaume, Schyns-Liharska Tsveta, Sutovic Dragana, Thalheim Christoph, Trojano Maria, Vlasov Yan V, Yaldizli Ozgür, EUReMS Consortium Multiple sclerosis registries in Europe - results of a systematic survey.
Mult Scler 2014 Oct;20(11):1523-32. Epub 2014 apr 28PMID:24777278
Finne Kenneth, Vethe Heidrun, Skogstrand Trude, Leh Sabine, Dahl Tone D, Tenstad Olav, Berven Frode S, Reed Rolf K, Vikse Bjørn Egil Proteomic analysis of formalin-fixed paraffin-embedded glomeruli suggests depletion of glomerular filtration barrier proteins in two-kidney, one-clip hypertensive rats.Nephrol Dial Transplant 2014 Dec;29(12):2217-27. Epub 2014 aug 16PMID:25129444
Helgeland Erik, Breivik Lars Ertesvåg, Vaudel Marc, Svendsen Øyvind Sverre, Garberg Hilde, Nordrehaug Jan Erik, Berven Frode Steingrimsen, Jonassen Anne Kristine
Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution.PLoS One 2014;9(10):e109279. Epub 2014 okt 15
PMID:25333471
Aasebø Elise, Vaudel Marc, Mjaavatten Olav, Gausdal Gro, Van der Burgh Arthur, Gjertsen Bjørn Tore, Døskeland Stein Ove, Bruserud Oystein, Berven Frode S, Selheim FrodePerformance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines.Proteomics 2014 Sep;14(17-18):1971-6. Epub 2014 aug 8PMID:25044641
Haaland Ingvild, Opsahl Jill A, Berven Frode S, Reikvam Håkon, Fredly Hanne K, Haugse Ragnhild, Thiede Bernd, McCormack Emmet, Lain Sonia, Bruserud Oystein, Gjertsen Bjørn ToreMolecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia.Mol Cancer 2014;13():116. Epub 2014 mai 21PMID:24885082
Vaudel Marc, Venne A Saskia, Berven Frode S, Zahedi René P, Martens Lennart, Barsnes HaraldShedding light on black boxes in protein identification.Proteomics 2014 May;14(9):1001-5. Epub 2014 mar 20PMID:24678044
Lichti Cheryl F, Liu Huiling, Shavkunov Alexander S, Mostovenko Ekaterina, Sulman Erik P, Ezhilarasan Ravesanker, Wang Qianghu, Kroes Roger A, Moskal Joseph C, Fenyö David, Oksuz Betül Akgöl, Conrad Charles A, Lang Frederick F, Berven Frode S, Végvári Akos, Rezeli Melinda, Marko-Varga György, Hober Sophia, Nilsson Carol L
Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines.J Proteome Res 2014 Jan 3;13(1):191-9. Epub 2013 des 3
PMID:24266786
Barsnes Harald, Vaudel Marc, Martens LennartJSparklines: Making tabular proteomics data come alive.Proteomics 2014 Nov 25. Epub 2014 nov 25PMID:25422159
Bjorlykke Yngvild, Vethe Heidrun, Vaudel Marc, Barsnes Harald, Berven Frode S, Tjora Erling, Raeder HelgeCarboxyl-Ester Lipase Maturity-Onset Diabetes of the Young Disease Protein Biomarkers in Secretin-Stimulated Duodenal Juice.J Proteome Res 2014 Nov 4. Epub 2014 nov 4PMID:25369532
Vaudel Marc, Barsnes Harald, Martens Lennart, Berven Frode SBioinformatics for proteomics: opportunities at the interface between the scientists, their experiments, and the community.Methods Mol Biol 2014;1156():239-48. PMID:24791993
Beck Florian, Geiger Jörg, Gambaryan Stepan, Veit Johannes, Vaudel Marc, Nollau Peter, Kohlbacher Oliver, Martens Lennart, Walter Ulrich, Sickmann Albert, Zahedi René P
Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.Blood 2014 Jan 30;123(5):e1-e10. Epub 2013 des 9PMID:24324209
Muth Thilo, Weilnböck Lisa, Rapp Erdmann, Huber Christian G, Martens Lennart, Vaudel Marc, Barsnes HaraldDeNovoGUI: an open source graphical user interface for de novo sequencing of tandem mass spectra.J Proteome Res 2014 Feb 7;13(2):1143-6. Epub 2014 jan 7PMID:24295440
Vaudel Marc, Sickmann Albert, Martens Lennart
Introduction to opportunities and pitfalls in functional mass spectrometry based proteomics.Biochim Biophys Acta 2014 Jan;1844(1 Pt A):12-20. Epub 2013 jul 9PMID:23845992
Oveland Eystein, Muth Thilo, Rapp Erdmann, Martens Lennart, Berven Frode S, Barsnes Harald Viewing the proteome: How to visualize proteomics data?Proteomics 2014 Dec 11. Epub 2014 des 11PMID:25504833
Kelchtermans Pieter, Bittremieux Wout, De Grave Kurt, Degroeve Sven, Ramon Jan, Laukens Kris, Valkenborg Dirk, Barsnes Harald, Martens Lennart
Machine learning applications in proteomics research: how the past can boost the future.Proteomics 2014 Mar;14(4-5):353-66. Epub 2014 jan 21PMID:24323524
Verheggen Kenneth, Barsnes Harald, Martens Lennart
Distributed computing and data storage in proteomics: many hands make light work, and a stronger memory.Proteomics 2014 Mar;14(4-5):367-77. Epub 2013 nov 27PMID:24285552
2013
Skår Anne Britt Rundhovde, Folkestad Helge, Smedal Tori, Grytten Nina
"I refer to them as my colleagues": the experience of mutual recognition of self, identity and empowerment in multiple sclerosis. Disabil Rehabil 2014;36(8):672-7. Epub 2013 jul 26 PMID: 23889526
Kampman Margitta T, Aarseth Jan Harald, Grytten Nina, Benjaminsen Espen, Celius Elisabeth Gulowsen, Dahl Ole Petter, Holmøy Trygve, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Risberg Geir, Vatne Anita, Torkildsen Oivind Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. J Neurol 2013 Jun;260(6):1481-8. Epub 2013 jan 6 PMID:23292231
Teunissen Charlotte, Menge Til, Altintas Ayse, Alvarez-Cermeño José C, Bertolotto Antonio, Berven Frode S, Brundin Lou, Comabella Manuel, Degn Matilde, Deisenhammer Florian, Fazekas Franz, Franciotta Diego, Frederiksen Jette L, Galimberti Daniela, Gnanapavan Sharmilee, Hegen Harald, Hemmer Bernhard, Hintzen Rogier, Hughes Steve, Iacobaeus Ellen, Kroksveen Ann C, Kuhle Jens, Richert John, Tumani Hayrettin, Villar Luisa M, Drulovic Jelena, Dujmovic Irena, Khalil Michael, Bartos Ales
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 2013 Nov;19(13):1802-9. Epub 2013 mai 21 PMID: 23695446
Berle Magnus, Kroksveen Ann Cathrine, Garberg Hilde, Aarhus Mads, Haaland Oystein Ariansen, Wester Knut, Ulvik Rune Johan, Helland Christian, Berven Frode
Quantitative proteomics comparison of arachnoid cyst fluid and cerebrospinal fluid collected perioperatively from arachnoid cyst patients. Fluids Barriers CNS 2013;10(1):17. Epub 2013 apr 29 PMID: 23628075
Provan F, Jensen L B, Uleberg K E, Larssen E, Rajalahti T, Mullins J, Obach A
Proteomic analysis of epidermal mucus from sea lice-infected Atlantic salmon, Salmo salar L. J Fish Dis 2013 Mar;36(3):311-21. Epub 2013 jan 11 PMID: 23305410
Feys Peter, Baert Ilse, Dalgas Ulrik, Smedal Tori Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis. Mult Scler 2013 Sep. Epub 2013 sep 3
PMID: 23999608
Kroksveen Ann C, Aasebø Elise, Vethe Heidrun, Van Pesch Vincent, Franciotta Diego, Teunissen Charlotte E, Ulvik Rune J, Vedeler Christian, Myhr Kjell-Morten, Barsnes Harald, Berven Frode S Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
J Proteomics 2013 Jan 14;78():312-25. Epub 2012 okt 8 PMID: 23059536
Xiao Yichuan, Jin Jin, Chang Mikyoung, Chang Jae-Hoon, Hu Hongbo, Zhou Xiaofei, Brittain George C, Stansberg Christine, Torkildsen Øivind, Wang Xiaodong, Brink Robert, Cheng Xuhong, Sun Shao-Cong Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation. Nat Med 2013 May;19(5):595-602. Epub 2013 apr 21
PMID: 23603814
Ban Maria, Caillier Stacy, Mero Inger-Lise, Myhr Kjell-Morten, Celius Elisabeth G, Aarseth Jan, Torkildsen Øivind, Harbo Hanne F, Oksenberg Jorge, Hauser Stephen L, Sawcer Stephen, Compston Alastair No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann Neurol 2013 Mar;73(3):430-2. Epub 2013 feb 26 PMID: 23444327
Løken-Amsrud Kristin I, Myhr Kjell-Morten, Bakke Søren J, Beiske Antonie G, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Šaltyte, Torkildsen Øivind, Wergeland Stig, Holmøy Trygve Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction.PLoS One 2013;8(1):e54417. Epub 2013 jan 22 PMID: 23349882
Løken-Amsrud Kristin I, Myhr Kjell-Morten, Bakke Søren J, Beiske Antonie G, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Torkildsen Øivind, Wergeland Stig, Holmøy Trygve
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler 2013 Apr;19(4):451-7. Epub 2012 aug 20 PMID: 22907941
Grytten Nina, Torkildsen Øivind, Aarseth Jan Harald, Benjaminsen Espen, Celius Elisabeth Gulowsen, Dahl Ole Petter, Holmøy Trygve, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Risberg Geir, Vatne Anita, Kampman Margitta T Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Mult Scler 2013 Jul;19(8):1028-34. Epub 2012 des 20 PMID: 23257620
Torkildsen Ø, Løken-Amsrud K I, Wergeland S, Myhr K-M, Holmøy T Fat-soluble vitamins as disease modulators in multiple sclerosis. Acta Neurol Scand Suppl 2013. PMID: 23190287
Haász Judit, Westlye Erling T, Fjær Sveinung, Espeseth Thomas, Lundervold Arvid, Lundervold Astri J General fluid-type intelligence is related to indices of white matter structure in middle-aged and old adults. Neuroimage 2013 Dec;83():372-83. Epub 2013 jun 19 PMID: 23791837
Totland Cecilie, Ying Ming, Haugen Mette, Mazengia Kibret, Storstein Anette, Aarseth Jan, Martinez Aurora, Vedeler Christian Avidity of onconeural antibodies is of clinical relevance. Cancer Immunol Immunother 2013 Aug;62(8):1393-6. Epub 2013 jun 4
PMID: 23733227
Bertelsen A K, Tøndel C, Krohn J, Bull N, Aarseth J, Houge G, Mellgren S I, Vedeler C A
Small fibre neuropathy in Fabry disease. J Neurol 2013 Mar;260(3):917-9. Epub 2012 des 21 PMID: 23263477
Lunde H M B, Bjorvatn B, Myhr K-M, Bø L
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. Acta Neurol Scand Suppl 2013. PMID: 23190288
Salzer Jonatan, Myhr Kjell-Morten
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No. Mult Scler 2013 Nov;19(13):1692-3. PMID: 24218487
eUtils.ItemsChoiceType2[], Beecham Ashley H, Patsopoulos Nikolaos A, Xifara Dionysia K, Davis Mary F, Kemppinen Anu, Cotsapas Chris, Shah Tejas S, Spencer Chris, Booth David, Goris An, Oturai Annette, Saarela Janna, Fontaine Bertrand, Hemmer Bernhard, Martin Claes, Zipp Frauke, D'alfonso Sandra, Martinelli-Boneschi Filippo, Taylor Bruce, Harbo Hanne F, Kockum Ingrid, Hillert Jan, Olsson Tomas, Ban Maria, Oksenberg Jorge R, Hintzen Rogier, Barcellos Lisa F, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Agliardi Cristina, Alfredsson Lars, Alizadeh Mehdi, Anderson Carl, Andrews Robert, Søndergaard Helle Bach, Baker Amie, Band Gavin, Baranzini Sergio E, Barizzone Nadia, Barrett Jeffrey, Bellenguez Céline, Bergamaschi Laura, Bernardinelli Luisa, Berthele Achim, Biberacher Viola, Binder Thomas M C, Blackburn Hannah, Bomfim Izaura L, Brambilla Paola, Broadley Simon, Brochet Bruno, Brundin Lou, Buck Dorothea, Butzkueven Helmut, Caillier Stacy J, Camu William, Carpentier Wassila, Cavalla Paola, Celius Elisabeth G, Coman Irène, Comi Giancarlo, Corrado Lucia, Cosemans Leentje, Cournu-Rebeix Isabelle, Cree Bruce A C, Cusi Daniele, Damotte Vincent, Defer Gilles, Delgado Silvia R, Deloukas Panos, di Sapio Alessia, Dilthey Alexander T, Donnelly Peter, Dubois Bénédicte, Duddy Martin, Edkins Sarah, Elovaara Irina, Esposito Federica, Evangelou Nikos, Fiddes Barnaby, Field Judith, Franke Andre, Freeman Colin, Frohlich Irene Y, Galimberti Daniela, Gieger Christian, Gourraud Pierre-Antoine, Graetz Christiane, Graham Andrew, Grummel Verena, Guaschino Clara, Hadjixenofontos Athena, Hakonarson Hakon, Halfpenny Christopher, Hall Gillian, Hall Per, Hamsten Anders, Harley James, Harrower Timothy, Hawkins Clive, Hellenthal Garrett, Hillier Charles, Hobart Jeremy, Hoshi Muni, Hunt Sarah E, Jagodic Maja, Jelcic Ilijas, Jochim Angela, Kendall Brian, Kermode Allan, Kilpatrick Trevor, Koivisto Keijo, Konidari Ioanna, Korn Thomas, Kronsbein Helena, Langford Cordelia, Larsson Malin, Lathrop Mark, Lebrun-Frenay Christine, Lechner-Scott Jeannette, Lee Michelle H, Leone Maurizio A, Leppä Virpi, Liberatore Giuseppe, Lie Benedicte A, Lill Christina M, Lindén Magdalena, Link Jenny, Luessi Felix, Lycke Jan, Macciardi Fabio, Männistö Satu, Manrique Clara P, Martin Roland, Martinelli Vittorio, Mason Deborah, Mazibrada Gordon, McCabe Cristin, Mero Inger-Lise, Mescheriakova Julia, Moutsianas Loukas, Myhr Kjell-Morten, Nagels Guy, Nicholas Richard, Nilsson Petra, Piehl Fredrik, Pirinen Matti, Price Siân E, Quach Hong, Reunanen Mauri, Robberecht Wim, Robertson Neil P, Rodegher Mariaemma, Rog David, Salvetti Marco, Schnetz-Boutaud Nathalie C, Sellebjerg Finn, Selter Rebecca C, Schaefer Catherine, Shaunak Sandip, Shen Ling, Shields Simon, Siffrin Volker, Slee Mark, Sorensen Per Soelberg, Sorosina Melissa, Sospedra Mireia, Spurkland Anne, Strange Amy, Sundqvist Emilie, Thijs Vincent, Thorpe John, Ticca Anna, Tienari Pentti, van Duijn Cornelia, Visser Elizabeth M, Vucic Steve, Westerlind Helga, Wiley James S, Wilkins Alastair, Wilson James F, Winkelmann Juliane, Zajicek John, Zindler Eva, Haines Jonathan L, Pericak-Vance Margaret A, Ivinson Adrian J, Stewart Graeme, Hafler David, Hauser Stephen L, Compston Alastair, McVean Gil, De Jager Philip, Sawcer Stephen J, McCauley Jacob L Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013 Nov;45(11):1353-60. Epub 2013 sep 29 PMID:
24076602
Lossius Andreas, Riise Trond, Pugliatti Maura, Bjørnevik Kjetil, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Magalhaes Sandra, Myhr Kjell-Morten, Pekmezovic Tatjana, Wesnes Kristin, Wolfson Christina, Holmøy Trygve Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. Mult Scler 2014 May;20(6):669-74. Epub 2013 sep 26 PMID: 24072723
Holmøy Trygve, Løken-Amsrud Kristin Ingeleiv, Bakke Søren Jacob, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Saltyte Benth Jutrate, Torkildsen Oivind, Wergeland Stig, Myhr Kjell-Morten, Michelsen Annika E, Aukrust Pål, Ueland Thor Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity. PLoS One 2013;8(9):e75021. Epub 2013 sep 19
PMID: 24069377
Leone Maurizio A, Barizzone Nadia, Esposito Federica, Lucenti Ausiliatrice, Harbo Hanne F, Goris An, Kockum Ingrid, Oturai Annette Bang, Celius Elisabeth Gulowsen, Mero Inger L, Dubois Bénédicte, Olsson Tomas, Søndergaard Helle Bach, Cusi Daniele, Lupoli Sara, Andreassen Bettina Kulle, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Myhr Kjell-Morten, Guerini Franca R, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Comi Giancarlo, Martinelli-Boneschi Filippo, D'alfonso Sandra Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One 2013;8(6):e64408. Epub 2013 jun 13 PMID: 23785401
eUtils.ItemsChoiceType2[]
Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. Am J Hum Genet 2013 Jun;92(6):854-65. Epub 2013 mai 23 PMID: 23731539
Mechelli Rosella, Umeton Renato, Policano Claudia, Annibali Viviana, Coarelli Giulia, Ricigliano Vito A G, Vittori Danila, Fornasiero Arianna, Buscarinu Maria Chiara, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Romano Silvia, Salvetti Marco, Ristori Giovanni A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis. PLoS One 2013;8(5):e63300. Epub 2013 mai 16 PMID: 23696811
Svenningsson Anders, Falk Eva, Celius Elisabeth G, Fuchs Siegrid, Schreiber Karen, Berkö Sara, Sun Jennifer, Penner Iris-Katharina, eUtils.ItemsChoiceType2[]
Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS One 2013;8(3):e58643. Epub 2013 mar 21 PMID: 23555589
Mero Inger-Lise, Gustavsen Marte W, Sæther Hanne S, Flåm Siri T, Berg-Hansen Pål, Søndergaard Helle B, Jensen Poul Erik H, Berge Tone, Bjølgerud Anja, Muggerud Aslaug, Aarseth Jan H, International Multiple Sclerosis Genetics Consortium, Myhr Kjell-Morten, Celius Elisabeth G, Sellebjerg Finn, Hillert Jan, Alfredsson Lars, Olsson Tomas, Oturai Annette Bang, Kockum Ingrid, Lie Benedicte A, Andreassen Bettina Kulle, Harbo Hanne F Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS One 2013;8(3):e58352. Epub 2013 mar 5 PMID: 23472185
Olsson Tomas, Achiron Anat, Alfredsson Lars, Berger Thomas, Brassat David, Chan Andrew, Comi Giancarlo, Eraksoy Mefkure, Hegen Harald, Hillert Jan, Jensen Poul Erik Hyldgaard, Moiola Lucia, Myhr Kjell-Morten, Oturai Annette, Schippling Sven, Siva Aksel, Sorensen Per Soelberg, Trampe Anne-Kathrin, Weber Thomas, Potts James, Plavina Tatiana, Paes Dominic, Subramanyam Meena, Wiendl Heinz, Dib Hussein, Uren Deniz, Hemmer Bernhard, Buck Dorothea Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. Mult Scler 2013 Oct;19(11):1533-8. Epub 2013 mar 4 PMID:
23459571
Comi Giancarlo, Martinelli Vittorio, Rodegher Mariaemma, Moiola Lucia, Leocani Letizia, Bajenaru Ovidiu, Carra Adriana, Elovaara Irina, Fazekas Franz, Hartung Hans-Peter, Hillert Jan, King John, Komoly Samuel, Lubetzki Catherine, Montalban Xavier, Myhr Kjell-Morten, Preziosa Paolo, Ravnborg Mads, Rieckmann Peter, Rocca Maria A, Wynn Daniel, Young Carolyn, Filippi Massimo Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. Mult Scler 2013 Jul;19(8):1074-83. Epub 2012 des 12 PMID: 23234810
Malm Johan, Fehniger Thomas E, Danmyr Pia, Végvári Akos, Welinder Charlotte, Lindberg Henrik, Appelqvist Roger, Sjödin Karin, Wieslander Elisabet, Laurell Thomas, Hober Sophia, Berven Frode S, Fenyö David, Wang Xiangdong, Andrén Per E, Edula Goutham, Carlsohn Elisabet, Fuentes Manuel, Nilsson Carol L, Dahlbäck Magnus, Rezeli Melinda, Erlinge David, Marko-Varga György Developments in biobanking workflow standardization providing sample integrity and stability. J Proteomics 2013 Dec;95():38-45. Epub 2013 jul 13 PMID: 23856607
Grytten N, Aarseth J H, Espeset K, Johnsen G B, Wehus R, Lund C, Haugstad R C
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis. Acta Neurol Scand 2013 Feb;127(2):133-40. Epub 2012 aug 25 PMID: 22924678
Fjær Sveinung, Bø Lars, Lundervold Arvid, Myhr Kjell-Morten, Pavlin Tina, Torkildsen Oivind, Wergeland Stig Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model. PLoS One 2013;8(12):e84162. Epub 2013 des 30
PMID: 24386344
Kvistad Silje Agnethe Stokke, Wergeland Stig, Torkildsen Øivind, Myhr Kjell-Morten, Vedeler Christian A [Neuromyelitis optica]. Tidsskr Nor Laegeforen 2013 Oct;133(19):2057-61. PMID: 24129537
Andre vitenskapelige publikasjoner og presentasjoner 2013
Grytten N, Aarseth, JH, Bøe Lunde HM, Myhr KM
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74-558
Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N
Month of Birth in Multiple Sclerosis. Confounders and adjustments
Poster at Charcot meeting Baveno 28. -30. November 2013
Grytten Torkildsen Ø, Grytten Torkildsen N
Kjønnsratio ved multippel sklerose
Best Practice
Grytten Torkildsen, N, Grytten Torkildsen Ø
Fødselsmåned og risiko for multippel sklerose
Best Practice nr. 13
Guldbrandsen A
In-depth characterization of the cerebrospinal fluid proteome.
Poster: 61st ASMS Conference on Mass Spectrometry and Allied Topics, Minneapolis 10.-14.Juni 2013
Oveland E.
Comparison of cuprizone and experimental autoimmune encephalomyelitis multiple sclerosis models using TMT and label-free quantit
Poster: 61st ASMS Conference on Mass Spectrometry and Allied Topics, Minneapolis 10.-14. Juni 2013
Oveland E.
TMT and label-free differential brain proteome analysis of two multiple sclerosis models in mice and verification in patients.
Poster: HUPO 12th Annual World Congress, Yokohama 14.-18. September 2013
Oveland E.
TMT and label-free quantitative proteomics: comparison of two multiple sclerosis models in mice. Foredrag.
8th Meeting of the Norwegian Proteomics Society, Oslo 4.-5. Mars 2013
Opsahl JA.
CSF proteome characterization- Dynamics of plasma proteins and CNS specific proteins in CSF
Poster: 61st ASMS Conference on Mass Spectrometry and Allied Topics, Minneapolis 10.-14. Juni 2013
HMB Lunde, S. Wergeland
Primær progressiv MS.
MS Rapporten: des.2013
Rajalahti T.
Multivariate approach to reveal biomarker signatures for disease classification, The 2013 Eastern Analytical Symposium.
Somerset, NJ, USA 18-20. Nov
Bleie O, Westerhuis J, Arneberg R, Rajalahti T, Smilde AK, Kvalheim OM
Selectivity ratio enhanced variable selection in latent variable regression models with continuous response variables.
Poster: 13th Scandinavian Symposium on Chemometrics, Djurönäset, Sverige, 17-20. Juni
Rajalahti T, Aadland E, Andersen JR, Våge V, Kvalheim OM
A multivariate approach to reveal biomarker signatures in instrumental profiles of body fluids.
Poster: The 9th Annual Conference of the Metabolomics Society, Glasgow, Skotland, 1-4. juli
Jones KØ, Smedal T
WalkAide – Experiences with a multidisciplinary model for testing, adjustment and follow-up.
RIMS; SIG mobility, Limerick 7-8 juni
Smedal T.
Quality of movement – does it matter, and can we change it?
ECTRIMS; SIG mobility, Limerick 7-8 juni
Jones K, Smedal T.
WalkAide - Experiences with a multidisciplinary model for testing, adjustment and follow-up.
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74-558
Skår AB, Kristensen B, Kaale H, Smedal T.
Patients` voices in the development of care pathways.
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl)74–558
Baert I, Freeman J, Smedal T et al.
Responsiveness and clinically meaningful change of walking measures after rehabilitation in multiple sclerosis: a European multi
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74-558
Stokke, S
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74–558
Fjær S, Wergeland S, Ahmad I, Bø L
Automatic quantification of histology using giga¬resolution microscopy
Poster: MedIm 2013
Nystad AE. Wergeland S, Aksnes L, Myhr KM, Bø L, Torkildsen Ø
High dose vitamin D3 improves remyelination and oligodendrocyte maturation in the cuprizone model
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74–558
Myhr KM
Tidig behandling er viktig ved MS. www.msnytt.no/Global/NO/Downloads/Newsletters/2013/2013-Q2-Tidlig-behandling-km-myhr.pdf
Novartis Nyhetsbrev
Myhr KM
Tidig behandling ved multippel sklerose. http://intra.cegedim.no/Biogen/20120406_Biogen_Nyhetsbrev/Nyhetsbrev/index2.html
Biogen Idec Nyhetsbrev
Myhr KM
Symptomatisk behandling er viktig ved kronisk nevrologisk sykdom
Best Practice
Myhr KM
Nytt system for systematisk metodevurdering – forhåpentligvis et fremskritt for helsetjenesten.
Best Practice
Myhr KM
Lavdose-naltrekson (LDN) ved multippel sklerose (MS).http://www.utposten-stiftelsen.no/Portals/14/2013Utposten/UP4_13/14_15_LDN%
Utposten 2013;4:14-15
Lossius A, Riise T, Pugliatti M, Wesnes K, Bjørnevik K, Granieri E, Casetta I, Drulovic J, Myhr KM, Lauer K, Kampman M, Magalhaes S, Pekmezovic T, Landtblom AM, Wolfson C, Holmøy T
Season and latitude of infectious mononucleosis and the risk of multiple sclerosis: the EnvIMS study
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74–558
Jacobsen CO, Bergsland N, Dalaker T, Farbu E, Hagemeier J, Larsen JP, Lode K, Myhr KM, Nyland H, Ramasamy D, Zivadinov R
Cortical and Subcortical Grey Matter Atrophy as Predictors of Cognitive Dysfunction in Patients with Multiple Sclerosis.
American Academy of Neurology (AAN) 21. mars
Jacobsen CO, Bergsland N, Dalaker T, Farbu E, Hagemeier J, Larsen JP, Lode K, Myhr KM, Nyland H, Ramasamy D, Zivadinov R
Cortical and Subcortical Grey Matter Atrophy as Predictors of Disability Progression in Patients with Multiple Sclerosis.
American Academy of Neurology (AAN) 21. mars
Baert, I, Freeman J, Smedal, T, Dalgas U, Romberg A, Conyers H, Elorriaga I, Gebara B, Gumse J, Heric A, Jensen E, Jones K, Kalron A, Knuts K, Maertens B, Martic A, Normann B, Op 't Eijnde B , Rasova K, Santoyo Medina C, Truyens V, Wens I, Feys P
Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehab.
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74–558
Kuhle, J Dobson R, Bestwick JP, Topping J, Dalla Costa G, Khademi M, Sombekke M, Killestein J, Evdoshenko E, Lazareva N, Runia T, Zborníková P, Horáková D, D'Alfonso S, Thouvenot E, Moll N, Hegen H, Rauch S, S, Myhr KM, Wergeland S, Torkildsen Ø
Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74–558
Lossius A, Riise T, Pugliatti M, Wesnes K, Bjørnevik K, Granieri E, Casetta I, Drulovic J, Myhr KM, Lauer K, Kampman MT, Magalhaes S, Pekmezovic T, Landtblom, A Wolfson C, Holmøy T
Season and latitude of infectious mononucleosis and the risk of multiple sclerosis: the EnvIMS study
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74–558
Hendrickson MChang A, Fisher E, Staugaitis S, Fox R, Mork S, rapp B
Myelocortical multiple sclerosis: a subgroup of multiple sclerosis patients with spinal cord and cortical demyelination
ECTRIMS: MULTIPLE SCLEROSIS JOURNAL vol. 19 (11 Suppl) 74–558
2012
Gavasso S, Torkildsen O, Marøy T H, Ulvestad E, Myhr K-M, Vedeler C A Fc? receptors in Norwegian multiple sclerosis patients and healthy controls. Acta Neurol Scand Suppl 2012. PMID: 23278662
Wergeland S, Torkildsen O, Bø L, Myhr K-M Polyunsaturated fatty acids in multiple sclerosis therapy. Acta Neurol Scand Suppl 2012. PMID: 23278660
Holmøy T, Torkildsen O, Myhr K-M, Løken-Amsrud K I Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore. Acta Neurol Scand Suppl 2012. PMID: 23278659
Torkildsen O, Grytten N, Aarseth J, Myhr K-M, Kampman M T
Month of birth as a risk factor for multiple sclerosis: an update. Acta Neurol Scand Suppl 2012. PMID: 23278658
Grytten Nina, Torkildsen Øivind, Aarseth Jan Harald, Benjaminsen Espen, Celius Elisabeth Gulowsen, Dahl Ole Petter, Holmøy Trygve, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Risberg Geir, Vatne Anita, Kampman Margitta T
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Mult Scler 2013 Jul;19(8):1028-34. Epub 2012 des 20 PMID: 23257620
Løken-Amsrud Kristin I, Myhr Kjell-Morten, Bakke Søren J, Beiske Antonie G, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Torkildsen Øivind, Wergeland Stig, Holmøy Trygve
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler 2013 Apr;19(4):451-7. Epub 2012 aug 20 PMID: 22907941
Wergeland Stig, Torkildsen Øivind, Myhr Kjell-Morten, Mørk Sverre Jarl, Bø Lars
The cuprizone model: regional heterogeneity of pathology. APMIS 2012 Aug;120(8):648-57. Epub 2012 feb 24 PMID: 22779688
Løken-Amsrud Kristin I, Holmøy Trygve, Bakke Søren J, Beiske Antonie Giaever, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Sandvik Leiv, Torkildsen Oivind, Wergeland Stig, Myhr Kjell-Morten
Vitamin D and disease activity in multiple sclerosis before and during interferon-ß treatment. Neurology 2012 Jul;79(3):267-73. Epub 2012 jun 13 PMID: 22700809
Kroksveen Ann C, Aasebø Elise, Vethe Heidrun, Van Pesch Vincent, Franciotta Diego, Teunissen Charlotte E, Ulvik Rune J, Vedeler Christian, Myhr Kjell-Morten, Barsnes Harald, Berven Frode S Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
J Proteomics 2013 Jan 14;78():312-25. Epub 2012 okt 8 PMID: 23059536
Kroksveen A C, Guldbrandsen A, Vedeler C, Myhr K M, Opsahl J A, Berven F S
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. Acta Neurol Scand Suppl 2012. PMID: 23278663
Grytten N, Aarseth J H, Espeset K, Johnsen G B, Wehus R, Lund C, Haugstad R C
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis. Acta Neurol Scand 2013 Feb;127(2):133-40. Epub 2012 aug 25 PMID: 22924678
Grytten N, Aarseth J H, Espeset K, Berg Johnsen G, Wehus R, Lund C, Riise T, Haugstad R
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study. Acta Neurol Scand Suppl 2012. PMID: 23278657
Gavasso S, Gjertsen BT, Anderssen E, Myhr KM, Vedeler C
Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis. Mult Scler 2012 Aug;18(8):1116-24. Epub 2012 jan 27 PMID: 22287540
Comi Giancarlo, Martinelli Vittorio, Rodegher Mariaemma, Moiola Lucia, Leocani Letizia, Bajenaru Ovidiu, Carra Adriana, Elovaara Irina, Fazekas Franz, Hartung Hans-Peter, Hillert Jan, King John, Komoly Samuel, Lubetzki Catherine, Montalban Xavier, Myhr Kjell-Morten, Preziosa Paolo, Ravnborg Mads, Rieckmann Peter, Rocca Maria A, Wynn Daniel, Young Carolyn, Filippi Massimo
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. Mult Scler 2013 Jul;19(8):1074-83. Epub 2012 des 12 PMID: 23234810
Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J, eUtils.ItemsChoiceType2[]
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 2012 Mar;78(11):841. PMID: 22411961
Mero Inger-Lise, Smestad Cathrine, Lie Benedicte A, Lorentzen Åslaug R, Sandvik Leiv, Landrø Nils Inge, Aarseth Jan H, Myhr Kjell-Morten, Celius Elisabeth G, Harbo Hanne F
Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course. J Neuroimmunol 2012 Mar;244(1-2):107-10. Epub 2012 feb 15 PMID: 22341604
Aye Thin Thin, Low Teck Yew, Bjørlykke Yngvild, Barsnes Harald, Heck Albert J R, Berven Frode S Use of stable isotope dimethyl labeling coupled to selected reaction monitoring to enhance throughput by multiplexing relative quantitation of targeted proteins.
Anal Chem 2012 Jun;84(11):4999-5006. Epub 2012 mai 15 PMID: 22548487
Pugliatti M, Eskic D, Mikolcic T, Pitschnau-Michel D, Myhr K-M, Sastre-Garriga J, Otero S, Wieczynska L, Torje C, Holloway E, Rienhoff O, Friede T, Buckow K, Ellenberger D, Hillert J, Glaser A, Flachenecker P, Fuge J, Schyns-Liharska T, Kasilingam E, Moretti A, Thalheim C, eUtils.ItemsChoiceType2[]
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS. Acta Neurol Scand Suppl 2012. PMID: 23278653
Bertelsen A K, Tøndel C, Krohn J, Bull N, Aarseth J, Houge G, Mellgren S I, Vedeler C A
Small fibre neuropathy in Fabry disease. J Neurol 2013 Mar;260(3):917-9. Epub 2012 des 21 PMID: 23263477
Boström Inger, Riise Trond, Landtblom Anne-Marie
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden Neuroepidemiology 2012;38(4):245-9. Epub 2012 jun 5 PMID: 22678224
Mjaavatten Olav, Nygaard Gyrid, Berven Frode S, Selheim Frode
Minimization of side reactions during Lys Tag derivatization of C-terminal lysine peptides. Anal Chim Acta 2012 Jan;712():101-7. Epub 2011 nov 19 PMID: 22177071
Gjelsvik Bente, Breivik Kyrre, Verheyden Geert, Smedal Tori, Hofstad Håkon, Strand Liv Inger The Trunk Impairment Scale - modified to ordinal scales in the Norwegian version. Disabil Rehabil 2012;34(16):1385-95. Epub 2011 des 23 PMID: 22191850
Bøe Lunde Hanne Marie, Aae Tommy F, Indrevåg William, Aarseth Jan, Bjorvatn Bjørn, Myhr Kjell-Morten, Bø Lars Poor sleep in patients with multiple sclerosis. PLoS One 2012;7(11):e49996. Epub 2012 nov 14 PMID: 23166808
Skrede Silje, Fernø Johan, Vázquez María Jesús, Fjær Sveinung, Pavlin Tina, Lunder Niclas, Vidal-Puig Antonio, Diéguez Carlos, Berge Rolf Kristian, López Miguel, Steen Vidar Martin Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. Int J Neuropsychopharmacol 2012 Mar;15(2):163-79. Epub 2011 aug 19
PMID: 21854679
Nesvåg Ragnar, Bergmann Ørjan, Rimol Lars M, Lange Elisabeth H, Haukvik Unn K, Hartberg Cecilie B, Fagerberg Thomas, Söderman Erik, Jönsson Erik G, Agartz Ingrid
A 5-year follow-up study of brain cortical and subcortical abnormalities in a schizophrenia cohort. Schizophr Res 2012 Dec;142(1-3):209-16. Epub 2012 okt 30 PMID: 23116883
Oveland Eystein, Karlsen Tine V, Haslene-Hox Hanne, Semaeva Elvira, Janaczyk Bartlomiej, Tenstad Olav, Wiig Helge Proteomic evaluation of inflammatory proteins in rat spleen interstitial fluid and lymph during LPS-induced systemic inflammation reveals increased levels of ADAMST1. J Proteome Res 2012 Nov;11(11):5338-49. Epub 2012 okt 24 PMID: 23025351
Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman M T, Landtblom A-M, Lauer K, Myhr K-M, Parpinel M, Pekmezovic T, Riise T, Zhu B, Wolfson C
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand Suppl 2012. PMID: 23278656
Myhr K-M, Grytten N, Aarseth J H
The norwegian multiple sclerosis registry and biobank. Acta Neurol Scand Suppl 2012. PMID: 23278652
Svendsen B, Myhr K-M, Nyland H, Aarseth J H
The cost of multiple sclerosis in Norway. Eur J Health Econ 2012 Feb;13(1):81-91. Epub 2010 nov 16 PMID: 21080024
Myhr K M, Grytten N, Torkildsen O, Wergeland S, Bø L, Pugliatti M, Aarseth J H
A need for national registries and international collaborative research in multiple sclerosis. Acta Neurol Scand Suppl 2012. PMID: 23278648
Saltyte Benth J, Myhr K-M, Løken-Amsrud K I, Beiske A G, Bjerve K S, Hovdal H, Midgard R, Holmøy T Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients. Neuroepidemiology 2012;39(2):84-93. Epub 2012 jul 17 PMID: 22814117
Torkildsen Oivind, Wergeland Stig, Bakke Søren, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Midgard Rune, Lilleås Finn, Pedersen Tom, Bjørnarå Bård, Dalene Frøydis, Kleveland Grethe, Schepel Jan, Olsen Inge Christoffer, Myhr Kjell-Morten
?-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol 2012 Aug;69(8):1044-51. PMID: 22507886
Andre vitenskapelige publikasjoner og presentasjoner 2012
Frugård J, Rokne B, Rundhovde Skår AB, Nortvedt M
Blæredysfunksjon hos personer med multippel sklerose
Sykepleien Forskning 2012;7(2)
N. Grytten Torkildsen, O. Torkildsen et al..
Month of birth is a latitude-dependent risk factor
ECTRIMS: Multiple Sclerosis Journal 2012; 18: (S4) 144-145
K. Wesnes, T. Riise, K. Bjørnevik et al.
The relationship between body size and the risk of multiple
ECTRIMS: Multiple Sclerosis Journal 2012; 18: (S4) 91
N. Barrizzone, M.A. Leone, F. Esposito, A. Lucenti, H.F...Myhr KM et al.
Association of genetic markers with the presence of
ECTRIMS: Multiple Sclerosis Journal 2012; 18: (S4) 130
H.K. Olberg, R.J. Cox, J.K. Nøstbakken, J.H. Aarseth, et al.
Does immunotherapy influence the vaccination response
ECTRIMS: Multiple Sclerosis Journal 2012; 18: (S4) 188
S. Gavasso, T. Marøy, E. Mosleth, K. Jørgensen, B.-T. Gjertsen et al.
Single cell Stats activation in immune cells reveals NAb effects
ECTRIMS: Multiple Sclerosis Journal 2012; 18: (S4) 468
K. Bjørnevik, T. Riise, K. Wesnes, E. Granieri, I. Casetta, J.
An age at exposure effect in the association between sun exposure
ECTRIMS: Multiple Sclerosis Journal 2012; 18: (S4) 15-16
Gavasso S, Marøy T, Mosleth E, Jørgensen K, Nakkestad HL, Gjertsen BT, Myhr BT, Vedeler CA
Single cell pStat1 activation, a promising biomarker to evaluate NAB effects in IFNB treated MS patients
ISNI 2012: Journal of Neuroimmunology 2012;253:S18
Myhr KM, Grytten Torkildsen N
Survival in MS: Current insights from International registries and databases.
International Journal of MS Care 2012 (14), Suppl. 4
Myhr K.M., Olberg H.K.a, Cox R., Nastbakken J.K., Aarseth J.H., Vedeler C.A.
The Influence of Immunomodulatory Therapy on Vaccination Response Among Patients with Multiple Sclerosis.
2nd International Congress on Neurology and Epidemiology. Nice, France, November 8–10, 2012. Neuroepidemiology 2012;39:S220
Wesnes, K.; Riise, T.; Pugliatti, M.; et al.
Overweight as a risk factor for multiple sclerosis
EFNS: EUROPEAN JOURNAL OF NEUROLOGY Volume: 19 Special Issue: SI Supplement: 1 Pages: 353-353
Lunde, H. M.; Aae, T.; Indrevag, W.; et al.
Poor sleep in patients with multiple sclerosis
EFNS: EUROPEAN JOURNAL OF NEUROLOGY Volume: 19 Special Issue: SI Supplement: 1 Pages: 706-706
Øen Jones K; Myhr, K. -M.; Skar, A. B. Rundhovde; et al.
WalkAide - A multidisciplinary model for adjustment and evaluation
RIMS: MULTIPLE SCLEROSIS JOURNAL Volume: 18 Issue: 5 Pages: S30-S30 Published: MAY 2012
Skar, A. B.; Smedal, T.; Torkildsen, N. G.
Recognition of self and identity is important for empowerment - A focus group-study in multiple sclerosis rehabilitation
RIMS: MULTIPLE SCLEROSIS JOURNAL Volume: 18 Issue: 5 Page: S58
Torkildsen, N. Grytten; Johnsen, G. B.; Espeseth, K.; et al.
Health related quality of life and disease modifying treatment continuation among multiple sclerosis patients
RIMS: MULTIPLE SCLEROSIS JOURNAL Volume: 18 Issue: 5 Page: S58
Nordvag, B-Y; Bernklev, T.; Slevolden, E.; KM Myhr et al.
Norwegian quality registry for biological drugs: the NOKBIL project
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY Volume: 41 Supplement: 126 Page: 50
Lunde HM, Bø L
Forekomst og behandling av søvnvansker ved Multippel Sklerose
Best Practice, 10.05.2012: 25-29
B. Svendsen
Kostnaden ved multippel sklerose i Norge
Best Practice 10.05.2012:9-13
KM Myhr
KM Myhr: Store fremskritt i diagnostikk og behandling - men også store utfordringer.
Best Practice, 12.11.2012:8
T. Tekand
Spastisitet ved multippel sklerose
Best Practice 12.11.2012:14-15
S. Glad
Arbeidsevne ved multippel sklerose
Best Practice 11.09.2012:36-39
KM Myhr
Norwegian hope for biomarker research in multiple sclerosis.
Pan European networks: Government. 2012;1:143
Glad SG, Aarseth JH, Nyland H, Riise T, Myhr KM
Arbeidsstatus ved benign MS
Nevrodagene, Oslo mars 2012:P38.
Lunde HMB, Aae TF, Indrevåg, W, Aarseth JH, Bø L.
MS og Søvn
Nevrodagene, Oslo mars 2012:P39
Mero IL, Gustavsen MW...Myhr KM, Harbeo HF et al.
Genetiske forskjeller med og uten oligoklonale bånd i speinalvæsken
Nevrodagene, Oslo mars 2012:P40
Løken-Amsrud KI, Myhr KM Holmøy T et al
Vitamin A og D er assosiert med sykdomsaktivitet ved MS
Nevrodagene, Oslo mars 2012:P42
Torkildsen Ø, Grytten Torkildsen N, Aarseth JH et al.
Fødselsmåned er en breddegradavhengig risikofaktor for MS i Norge
Nevrodagene, Oslo mars 2012:P43
Wergeland S, Fjær S, Bø L
Magnetization Transfer Imaging - in vivo deteksjon av endringer i myelininnhold
Nevrodagene, Oslo mars 2012:P45
Myhr KM
Developing high quality research.
Public Service review: European Union 2012: issue 23:176-177.
Fjær S et al
Comparison of SNR and reproducibility of MTR on 7 Tesla scanners in Bergen and Trondheim.
Abstrakt: MedIm ,Trondheim 2012
Fjær S et al
Regional assessment of Magnetization Transfer Ratio in the mouse brain.
Abstrakt: ISMRM, Melbourne 2012
TT Aye, TY Low, Y Bjørlykke, H Barsnes, AJR Heck, F Berven.
Stable Isotope Dimethyl Labeling Coupled to SRM Enhances Throughput by Multiplexing Relative Quantitation of Targeted Proteins.
Abstrakt: HUPO 11th Annual World Congress, Boston 2012
Astrid Guldbrandsen
Glycoproteomics in Human Cerebrospinal Fluid. Mapping the CSF Proteome,and Biomarker Discovery and Qualification in MS
Masteroppgave, UiB 2012
Heidrun Vethe
Mass spectrometry-based proteomics of human cerebrospinal fluid. Biomarker discovery and verification in MS
Masteroppgave, UiB 2012
Ann Cathrine Kroksveen
Quantitative proteomics analysis of cerebrospinal fluid - Biomarker discovery and verification in MS
PhD Thesis UiB 2012
Glad S
Å leve med multippel sklerose - bokanmeldelse
Tidsskr Nor Legeforen 2012; 132:552
Aarseth JH, Myhr KM, Grytten Torkildsen N.
Norsk Multippel Sklerose Register og Biobank
Nasjonal kvalitetsregisterkonferanse, Bergen, april, 2012
Aarseth JH, Myhr KM, Grytten Torkildsen N
Norsk Multippel Sklerose Register og Biobank
Internasjonalt MS-symposium, Os 17.-18. april, 2012
Glad SB, Aarseth JH, Nyland HI, Riise T, Myhr KM
The definition of benign multiple sclerosis: a methodical approach
Internasjonalt MS-symposium, Os 17.-18. april, 2012
Gavasso S
Immunogenic effects of recombinant IFNB therapy disrupt the JAK/STATs pathway in primary immune cells from patients with MS
Internasjonalt MS-symposium, Os 17.-18. april, 2012
Harkjerr MH
CNS demyelining disease - Akutt disseminert encefalomyelitt (ADEM).
Studentoppgave UiB 2012
Grytten Torkildsen N, Grytten Torkildsen Ø, Aarseth JH, Myhr KM, Kampman M
Fødselsmåned som risikofaktor for multippel sklerose
Nasjonal kvalitetsregisterkonferanse, Bergen, april, 2012
Gjerald H
Assessment of bladder dysfunction in multiple sclerosis
RIMS: MULTIPLE SCLEROSIS JOURNAL Volume: 18 Issue: 5 Page: S51